TSS:Hg 142538.1

Basic information about the TSS

---

TSS ID: hg_142538.1 Species: human Chr: chr14		Start: 24146371 End: 24146403 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000559056.5 Distance: 58 GeneID: 5721 HGNC/MGI_ID: HGNC:9569 UniProt_ID: H0YKU2

Gene_name: proteasome activator subunit 2 Gene_symbol: PSME2 Gene_synonyms: PA28beta Gene_source: HGNC:9569

TATA-Box annotation

---

Distance to TSS:	223
Nearest PromoterID:	NM_002818
Entrez ID:	5721
Nearest Unigene:	Hs.434081
Nearest Refseq:	NM_002818
Nearest Ensembl:	ENSG00000100911
Gene Name:	proteasome activator subunit 2
Gene Alias:	PA28B|PA28beta|REGbeta
Gene Description:	proteasome activator subunit 2
Gene Type:	protein-coding
CpG%:	0.015
GC%:	0.572139
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PSME2 p2@PSME2 p3@PSME2 p4@PSME2 p6@PSME2 p7@PSME2 p8@PSME2
Sample		p1@PSME2	p2@PSME2	p3@PSME2	p4@PSME2	p6@PSME2	p7@PSME2	p8@PSME2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	35.45	1.95	3.31	1.95	0.00	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	31.56	1.62	3.64	1.82	0.00	0.00	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	39.16	2.31	4.24	2.51	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	30.98	3.12	4.16	1.66	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	33.29	2.02	1.80	1.57	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	35.08	2.13	2.13	1.16	0.00	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	45.32	4.36	5.01	2.83	0.00	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	40.45	1.45	2.42	1.45	0.00	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	41.67	4.06	2.56	1.71	0.00	0.00	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	45.21	4.06	9.85	8.11	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	47.30	5.26	9.70	4.45	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	34.56	2.03	8.13	2.44	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	42.72	7.41	9.03	6.93	0.00	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	39.09	5.86	4.96	5.86	0.00	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	34.25	5.05	7.68	4.83	0.88	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	26.41	5.28	4.28	5.28	0.25	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	31.89	4.37	3.49	5.02	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	35.43	2.95	3.37	5.48	0.00	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	33.59	5.33	9.06	5.33	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	46.64	5.27	6.17	8.88	0.60	0.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	41.70	5.21	6.01	5.75	0.53	0.80	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	42.12	7.25	10.01	5.87	0.52	1.04	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	35.03	4.91	3.49	4.91	0.13	1.16	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	33.97	5.58	8.01	4.61	1.46	0.73	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	39.21	8.00	6.97	3.35	0.26	3.10	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	39.56	7.28	5.70	4.75	0.32	1.58	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	37.91	6.04	4.95	4.40	0.00	2.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	46.91	8.72	4.72	8.02	1.41	1.89	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	41.83	6.30	5.65	5.49	0.97	2.26	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	47.05	8.87	4.16	3.98	0.90	1.63	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	46.89	5.02	5.23	5.44	1.67	3.14	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	45.13	7.03	4.49	4.10	1.17	1.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	44.95	5.91	4.22	4.85	0.84	1.69	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	66.47	9.73	4.62	4.78	3.13	3.46	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	53.85	5.98	3.74	3.74	0.93	2.24	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	53.27	5.75	4.41	3.83	1.34	1.72	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	67.85	7.77	4.29	4.91	2.86	4.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	50.77	6.45	2.62	4.03	1.81	3.02	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	61.31	7.29	3.24	3.78	1.62	4.32	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	67.46	6.24	3.36	4.56	1.44	2.64	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	59.52	7.29	3.29	5.18	0.94	3.06	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	74.81	7.61	4.54	5.27	3.07	5.27	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	78.24	7.17	1.69	4.22	2.11	6.54	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	69.58	9.62	4.72	5.94	2.80	4.37	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	78.90	11.04	4.62	3.21	2.41	6.83	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	91.20	11.17	3.95	5.58	1.86	6.75	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	68.37	8.64	1.68	3.60	1.44	5.04	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	98.06	10.13	5.36	5.07	3.58	5.66	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	82.82	12.69	3.83	5.03	2.15	6.46	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	93.21	10.31	2.83	5.66	5.86	7.08	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	90.18	8.61	5.53	5.94	3.89	10.66	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	107.63	11.79	2.67	5.78	6.67	10.45	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	195.89	27.98	0.00	0.00	0.00	55.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	63.52	9.23	2.48	3.90	3.19	7.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	75.56	9.28	1.99	3.98	3.98	7.95	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	171.14	21.81	5.87	5.03	8.39	11.75	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	133.64	9.64	4.13	7.81	5.51	9.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	87.83	7.45	3.57	5.51	3.57	7.78	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	80.29	7.07	1.93	1.61	4.82	4.18	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	186.40	19.17	0.94	4.40	11.94	20.75	3.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	100.12	20.45	2.12	5.64	2.12	5.64	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	90.85	8.41	2.24	5.05	3.36	5.05	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	247.60	46.18	4.78	4.78	4.78	14.33	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	201.82	28.54	3.06	8.83	7.14	11.55	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	117.30	12.35	2.60	4.87	1.62	8.12	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	129.57	16.68	2.48	2.84	0.35	3.90	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	420.26	80.82	0.00	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	710.77	78.97	7.90	7.90	7.90	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	161.86	22.91	0.98	1.95	0.98	4.39	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	140.33	26.28	1.49	1.49	0.99	4.96	3.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	155.28	20.17	0.47	0.47	2.81	3.75	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	275.55	39.41	0.66	4.64	2.32	4.64	3.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	169.21	20.11	1.55	2.47	2.47	3.71	3.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	160.52	18.65	1.22	3.36	1.22	5.81	2.14
Adipocyte - breast, donor1	11376-118A8	14.25	1.74	2.38	1.90	0.32	0.00	0.00
Adipocyte - breast, donor2	11327-117E4	17.65	3.05	2.09	0.80	0.16	0.00	0.00
Adipocyte - omental, donor1	11473-119C6	20.61	1.91	2.42	2.04	0.38	0.13	0.13
Adipocyte - omental, donor2	11474-119C7	17.19	0.75	1.49	0.75	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	18.42	1.67	2.68	2.01	0.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	22.97	0.64	1.91	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	16.49	2.20	1.10	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	84.91	8.13	1.35	0.00	0.45	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	20.33	3.30	2.09	4.52	0.00	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	52.61	4.50	3.52	2.54	0.00	0.39	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	51.48	4.63	3.60	3.86	0.00	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	70.81	6.41	1.12	0.56	0.00	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	84.06	4.11	2.94	4.11	0.59	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	50.99	5.47	3.54	1.53	0.08	0.08	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	83.27	8.71	0.97	1.94	0.32	0.00	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	37.32	5.33	0.00	0.53	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	42.29	3.34	2.78	2.23	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	42.84	4.16	3.33	2.50	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	55.51	3.77	2.51	1.26	0.00	0.00	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	31.09	4.58	2.29	2.95	0.65	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	19.49	2.44	2.44	0.30	0.30	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	73.15	5.30	1.10	1.33	0.22	0.66	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	29.76	4.30	1.43	1.43	0.00	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	19.17	4.79	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	34.36	5.58	0.54	4.68	0.00	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	13.39	1.67	0.00	5.02	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	25.06	6.57	0.82	4.73	0.00	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	50.23	7.55	0.80	1.26	0.23	0.00	0.34
Anulus Pulposus Cell, donor2	11463-119B5	33.80	6.12	2.45	1.71	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	66.50	11.23	1.80	2.25	0.00	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	66.86	8.68	1.30	1.30	1.30	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	70.63	12.84	0.00	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	74.13	8.67	0.90	2.09	0.60	0.90	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	68.29	7.59	0.00	1.26	2.53	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	70.63	9.24	0.00	3.30	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	70.83	10.40	1.30	1.95	0.65	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	65.05	6.80	0.97	1.46	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	58.79	11.28	2.97	0.59	0.59	0.59	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	63.65	7.53	0.75	0.75	0.00	0.75	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	71.84	6.53	2.90	2.18	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	53.91	10.03	1.25	1.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	103.12	11.53	1.15	2.31	0.16	0.49	0.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	69.60	24.57	1.36	0.00	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	69.97	6.79	0.45	0.75	0.30	0.15	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	70.72	10.18	0.00	1.61	0.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	62.35	7.56	1.13	0.38	0.57	0.57	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	59.07	8.55	0.00	1.07	0.27	0.27	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	67.31	10.73	0.98	0.00	0.00	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	64.02	9.29	0.50	1.49	0.50	0.66	1.16
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	67.24	4.80	1.20	2.40	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	67.26	10.62	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	59.86	7.03	0.69	2.23	0.51	0.34	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	79.70	4.19	0.00	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	66.02	10.19	2.43	2.43	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	69.06	9.11	1.14	1.14	0.76	0.38	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	56.93	7.27	2.42	0.00	0.00	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	60.99	7.98	1.71	0.57	0.57	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	58.15	8.34	2.57	1.50	0.43	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	60.39	5.94	0.77	1.29	0.77	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	73.67	7.04	0.94	1.41	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	64.95	7.40	0.32	0.96	0.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	75.63	10.70	1.43	1.43	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	63.17	8.77	0.58	0.58	0.58	0.58	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	63.53	5.12	1.51	0.90	0.30	0.00	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	65.34	2.38	0.00	0.00	0.00	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	68.66	7.63	0.51	1.53	1.02	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	67.75	8.66	2.04	3.31	0.25	0.25	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	65.44	10.80	1.27	0.64	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	66.02	13.38	0.86	2.16	0.43	1.29	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	66.26	6.56	1.06	0.64	0.42	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	58.00	9.28	1.45	0.87	0.58	0.29	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	70.86	4.72	0.00	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	62.55	7.12	0.68	1.53	0.51	0.51	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	44.01	2.32	0.00	0.00	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	92.95	0.00	0.00	2.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	59.39	6.43	0.86	0.86	0.86	0.43	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	58.36	4.81	0.60	2.41	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	83.10	9.48	0.73	0.73	0.73	2.19	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	64.83	8.28	0.23	1.38	1.15	0.69	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	56.11	10.20	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	87.71	10.68	1.27	1.53	1.78	0.76	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	82.37	5.99	0.41	1.03	0.41	1.86	1.03
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	66.71	10.10	0.92	1.53	0.92	0.31	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	73.61	6.69	0.00	0.48	0.48	0.00	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	71.84	7.98	0.44	2.00	0.67	1.11	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	94.60	10.68	1.53	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	84.19	11.08	1.11	2.22	0.55	0.55	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	68.32	8.47	1.32	0.79	1.32	1.59	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	61.06	9.45	1.45	1.82	1.09	1.09	0.00
Astrocyte - cerebellum, donor1	11500-119F6	128.22	6.88	3.32	0.86	0.12	0.00	0.25
Astrocyte - cerebellum, donor2	11580-120F5	55.28	6.68	2.05	1.37	0.00	0.00	0.51
Astrocyte - cerebellum, donor3	11661-122F5	27.48	2.52	2.10	1.68	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	89.93	10.46	5.93	4.18	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	72.64	11.65	2.75	3.07	0.00	0.00	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	91.58	10.59	2.09	2.54	0.15	0.15	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	291.65	14.79	14.22	6.65	0.23	0.11	3.90
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	325.36	20.80	11.65	8.39	0.63	0.13	5.26
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	313.96	14.11	14.34	8.08	0.00	0.11	3.41
Basophils, donor1	12241-129G9	172.61	4.97	1.83	4.18	0.00	0.00	1.57
Basophils, donor2	12242-129H1	104.27	5.05	8.66	6.49	0.36	0.00	1.44
Basophils, donor3	12243-129H2	113.92	3.09	3.67	2.35	0.15	0.00	2.20
Bronchial Epithelial Cell, donor1	11511-119G8	25.66	2.37	1.08	0.86	0.22	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	17.83	1.37	0.46	1.37	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	39.54	1.26	1.26	0.63	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	41.59	4.57	0.21	1.04	0.00	0.00	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	32.47	5.30	0.46	2.76	0.23	0.00	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	32.21	2.34	0.72	1.80	0.18	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	217.24	7.83	17.73	8.14	0.00	0.00	1.65
Burkitt's lymphoma cell line:RAJI	10476-106I8	245.01	10.25	22.36	6.52	0.00	0.00	1.86
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	239.83	12.47	8.95	7.04	0.00	0.00	3.84
CD133+ stem cells - cord blood derived, pool1	12223-129E9	165.47	0.00	31.03	20.68	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	100.88	2.82	5.64	1.69	0.56	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	59.02	2.78	3.16	4.27	0.37	0.00	0.19
CD14+ Monocytes, donor3	11381-118B4	82.77	2.85	4.61	5.93	0.22	0.00	2.41
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	73.31	3.68	6.23	1.70	0.28	0.00	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	63.68	5.69	3.79	2.65	0.38	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	56.21	4.27	5.92	0.99	0.66	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	82.25	2.31	1.73	3.47	0.00	0.00	1.16
CD14+ monocytes - mock treated, donor2	11873-125C1	63.67	3.32	0.30	1.81	0.00	0.00	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	114.18	2.13	2.13	1.66	0.00	0.24	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	70.31	3.35	0.67	0.33	0.17	0.00	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	46.37	1.66	0.83	1.38	0.28	0.00	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	106.36	3.47	0.50	1.98	0.00	0.00	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	132.36	2.35	1.17	1.57	0.00	0.20	1.17
CD14+ monocytes - treated with BCG, donor2	11870-125B7	101.49	3.56	1.78	3.03	0.53	0.00	1.07
CD14+ monocytes - treated with BCG, donor3	11880-125C8	267.47	6.31	1.09	2.18	0.65	0.22	1.74
CD14+ monocytes - treated with Candida, donor1	11868-125B5	76.09	2.81	0.47	2.11	0.00	0.00	1.40
CD14+ monocytes - treated with Candida, donor2	11878-125C6	46.47	3.70	1.06	2.11	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	84.31	5.55	1.11	8.87	0.00	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	80.92	3.27	1.34	1.34	0.15	0.00	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	59.27	1.60	0.40	1.20	0.20	0.00	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	175.93	5.83	0.62	0.83	0.00	0.00	1.46
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	105.24	3.43	0.46	2.52	0.00	0.00	2.06
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	75.10	2.04	1.36	2.04	0.23	0.00	1.13
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	101.70	3.93	0.00	0.87	0.00	0.00	2.18
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	161.39	3.23	1.88	4.57	0.00	0.27	0.81
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	125.79	4.71	2.44	3.84	0.17	0.17	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	174.64	8.00	1.26	7.15	0.00	0.00	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	94.24	3.49	0.73	1.84	0.18	0.18	0.55
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	53.19	1.41	0.35	1.41	0.00	0.00	1.06
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	97.40	3.51	1.32	0.44	0.00	0.00	1.75
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	110.20	5.23	1.92	1.39	0.00	0.17	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	94.41	3.72	1.86	2.23	0.37	0.00	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	246.80	5.82	2.59	2.37	0.00	0.43	2.16
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	81.08	4.91	2.46	4.09	0.41	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	73.48	3.01	0.46	0.70	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	183.27	4.64	0.23	3.02	0.00	0.23	1.86
CD14+CD16+ Monocytes, donor1	11789-124B7	498.27	11.99	1.09	5.67	0.00	0.22	3.71
CD14+CD16+ Monocytes, donor2	11801-124D1	486.24	9.93	1.85	4.39	0.23	0.23	3.70
CD14+CD16+ Monocytes, donor3	11912-125G4	689.49	19.93	2.60	2.60	0.22	0.00	4.98
CD14+CD16- Monocytes, donor1	11788-124B6	240.12	7.94	4.67	5.92	0.00	0.00	2.02
CD14+CD16- Monocytes, donor2	11799-124C8	223.37	6.99	3.49	4.89	0.00	0.00	1.92
CD14+CD16- Monocytes, donor3	11910-125G2	207.58	7.14	4.24	5.80	0.00	0.00	1.11
CD14-CD16+ Monocytes, donor1	11790-124B8	432.78	15.82	1.79	6.12	0.00	0.26	3.06
CD14-CD16+ Monocytes, donor2	11800-124C9	331.76	8.78	3.29	6.15	0.00	0.00	5.49
CD14-CD16+ Monocytes, donor3	11911-125G3	451.83	13.26	4.63	7.58	0.00	0.00	2.74
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	180.88	16.26	12.19	8.13	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	143.05	8.81	12.88	6.10	0.00	0.00	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	152.23	8.28	8.28	4.14	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	197.76	9.59	11.19	7.46	0.00	0.00	1.60
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	152.24	8.04	9.65	5.36	0.00	0.00	2.68
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	161.45	11.23	16.14	9.83	0.00	0.00	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	193.74	13.33	14.12	5.49	0.00	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	177.97	9.23	10.55	7.91	0.00	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	47.67	1.64	18.08	9.04	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	64.56	2.90	14.51	6.53	0.00	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	40.39	2.52	14.14	6.56	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	122.83	5.25	4.04	2.02	0.00	0.00	2.83
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	102.67	4.39	3.99	2.80	0.00	0.00	2.80
CD34+ Progenitors, donor1	11545-120B6	60.24	8.03	6.02	8.03	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	54.50	2.25	6.18	2.25	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	232.97	11.65	7.14	4.13	0.00	0.00	1.88
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	252.77	17.14	13.53	5.19	0.00	0.00	2.03
CD4+ T Cells, donor1	11225-116C1	88.19	3.57	23.21	6.78	0.00	0.36	0.36
CD4+ T Cells, donor2	11306-117C1	72.26	5.51	14.08	6.74	0.00	0.00	0.61
CD4+ T Cells, donor3	11382-118B5	76.55	5.49	17.38	5.79	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	255.75	10.72	8.93	3.06	0.26	0.00	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	231.34	9.43	6.29	2.47	0.00	0.00	1.35
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	187.14	11.21	14.09	5.46	0.00	0.00	1.44
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	144.60	7.11	21.81	14.22	0.00	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	161.53	8.43	32.31	5.62	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	181.29	16.48	19.78	3.30	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	223.13	9.54	14.31	6.07	0.00	0.00	0.87
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	229.28	11.35	11.69	6.95	0.00	0.17	1.36
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	223.11	10.32	14.19	9.67	0.00	0.00	1.93
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	171.25	8.52	12.55	6.28	0.00	0.00	1.34
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	195.31	13.98	14.67	9.08	0.00	0.00	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	196.23	7.48	17.16	5.72	0.00	0.00	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	314.12	10.12	9.28	7.59	0.00	0.00	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	234.99	8.31	12.47	8.93	0.00	0.00	0.83
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	215.51	9.02	12.36	9.69	0.00	0.00	1.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	132.16	8.97	29.91	5.71	0.00	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	132.38	11.79	35.91	9.65	0.00	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	200.84	10.76	35.86	10.76	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	293.72	15.39	15.76	6.86	0.00	0.00	2.41
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	291.78	9.75	10.18	4.33	0.00	0.00	0.87
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	228.65	7.99	13.03	6.94	0.00	0.00	1.68
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	255.33	19.21	11.12	4.55	0.00	0.00	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	265.15	15.60	17.33	10.83	0.00	0.00	1.73
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	242.31	11.77	21.35	8.28	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	228.63	12.87	23.26	7.92	0.00	0.00	2.47
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	262.18	14.77	13.85	6.46	0.00	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	284.75	18.15	12.56	4.19	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	242.31	8.03	29.91	4.98	0.00	0.00	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	253.49	10.55	28.96	6.13	0.00	0.00	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	207.90	6.16	18.48	4.62	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	208.78	13.61	22.92	6.45	0.00	0.00	1.79
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	282.54	16.62	15.23	4.15	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	102.15	5.24	13.10	9.17	0.00	0.00	0.98
CD8+ T Cells, donor2	11307-117C2	57.82	4.13	8.26	6.76	0.38	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	83.57	6.06	20.45	10.86	0.00	0.00	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	146.35	11.01	3.67	6.65	0.00	0.23	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	121.98	8.63	4.55	5.27	0.00	0.24	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	150.75	14.23	3.83	6.02	0.27	0.00	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	198.44	11.11	4.50	6.00	0.60	0.00	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	120.47	9.12	5.04	6.24	0.00	0.24	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	148.94	10.91	3.18	4.78	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	179.26	11.73	3.48	3.69	0.00	0.00	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	183.19	10.53	1.58	5.53	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	166.74	13.60	2.58	4.46	0.23	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	242.41	16.60	5.74	5.74	0.00	0.00	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	248.96	17.43	3.78	7.55	0.29	0.29	1.16
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	265.10	18.92	4.26	5.33	0.27	0.00	0.80
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	114.25	5.69	2.19	6.13	0.00	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	122.51	12.30	4.10	7.29	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	91.74	5.97	3.73	9.70	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	137.58	11.16	3.24	6.84	0.00	0.00	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	124.01	9.49	3.74	5.47	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	121.15	10.84	4.24	6.36	0.71	0.00	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	190.46	17.43	2.54	4.12	0.00	0.32	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	173.77	16.30	5.23	5.54	0.31	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	170.23	13.46	5.45	3.85	0.00	0.64	1.28
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	196.59	14.15	2.29	4.97	0.00	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	167.10	11.82	2.36	3.94	0.00	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	191.37	12.86	2.27	3.78	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	122.85	12.85	10.44	16.86	1.61	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	133.59	9.79	14.69	20.28	0.70	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	139.24	13.02	6.01	14.02	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	71.28	9.14	1.83	7.31	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	110.68	8.89	0.99	1.98	0.00	0.00	0.99
Cardiac Myocyte, donor3	11686-122I3	58.09	4.95	0.21	0.32	0.11	0.00	0.53
Chondrocyte - de diff, donor1	11261-116G1	73.49	2.77	2.43	5.20	0.00	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	49.04	4.26	1.42	1.07	0.36	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	37.09	5.12	2.16	4.10	0.34	0.00	0.11
Chondrocyte - re diff, donor2	11339-117F7	94.00	6.27	0.90	2.69	0.90	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	55.00	6.47	4.04	4.04	0.00	0.40	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	113.61	10.33	3.79	1.72	0.23	0.11	0.92
Ciliary Epithelial Cells, donor2	11323-117D9	85.72	7.70	2.14	2.14	0.00	0.21	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	74.07	8.14	2.65	2.39	0.09	0.09	0.27
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	49.89	4.03	11.83	5.32	0.09	0.37	0.18
Corneal Epithelial Cells, donor1	11526-119I5	46.55	4.61	0.44	2.42	0.00	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	52.33	3.41	2.28	2.28	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	49.85	5.11	0.51	2.56	0.26	0.00	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	107.15	8.42	3.14	4.46	0.17	0.66	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	118.59	9.15	3.47	4.10	0.32	0.00	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	79.37	6.90	3.45	3.45	0.00	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	98.49	8.75	2.81	2.16	0.43	0.76	0.76
Dendritic Cells - plasmacytoid, donor1	11228-116C4	93.95	8.54	14.69	3.76	0.00	0.34	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	251.36	15.67	13.06	4.57	0.00	0.00	3.92
Dendritic Cells - plasmacytoid, donor3	11385-118B8	123.89	15.97	16.45	3.39	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	43.86	7.50	0.50	0.83	0.00	0.00	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	40.49	5.87	0.00	0.59	0.00	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	31.39	5.09	1.13	0.85	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	37.75	5.90	0.00	0.79	0.00	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	36.07	4.94	1.16	1.75	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	36.47	5.65	1.41	1.88	0.00	0.00	0.24
Endothelial Cells - Artery, donor3	11413-118E9	42.95	6.84	0.18	0.18	0.00	0.00	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	58.74	6.65	1.77	1.11	0.00	0.22	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	46.25	3.96	1.52	1.52	0.61	0.00	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	41.72	4.23	2.54	1.41	0.28	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	68.34	3.86	1.19	1.78	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	53.63	12.50	0.00	1.56	0.52	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	28.78	5.53	1.28	1.70	0.14	0.00	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	52.82	6.40	0.80	2.40	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	37.21	8.91	1.57	1.05	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	99.77	10.69	1.99	2.48	0.12	0.12	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	52.58	9.13	1.96	3.04	0.00	0.00	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	53.61	8.30	1.83	2.08	0.00	0.00	0.37
Endothelial Cells - Vein, donor1	11267-116G7	31.85	4.55	0.00	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	23.75	3.49	0.70	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	42.39	5.50	0.79	0.79	0.00	0.00	0.00
Eosinophils, donor1	12244-129H3	30.49	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	77.56	1.65	13.20	6.60	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	64.20	3.57	7.13	3.57	7.13	7.13	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	36.40	3.18	0.73	0.73	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	8.32	0.00	0.00	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	65.08	0.00	0.00	16.27	0.00	16.27	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	38.59	4.93	1.64	3.69	1.23	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	55.84	5.04	0.55	0.99	0.88	0.88	0.55
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	52.98	6.07	1.08	4.12	0.11	0.22	0.43
Fibroblast - Aortic Adventitial, donor1	11245-116E3	71.80	6.06	1.21	2.43	0.24	0.24	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	75.61	7.64	6.69	6.82	1.64	1.36	0.96
Fibroblast - Aortic Adventitial, donor2	11326-117E3	45.35	5.27	1.05	2.00	0.21	0.21	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	33.46	2.11	11.59	7.64	0.26	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	55.48	8.30	2.66	2.66	0.33	0.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	49.90	5.90	0.45	1.81	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	45.48	3.79	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	45.74	4.73	1.73	2.84	0.00	0.00	0.47
Fibroblast - Cardiac, donor4	11452-119A3	43.34	6.67	2.12	1.82	0.00	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	54.57	4.70	1.52	1.90	0.13	0.00	0.00
Fibroblast - Cardiac, donor6	11460-119B2	52.00	8.94	0.76	1.21	0.15	0.00	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	49.84	4.69	2.01	0.94	0.27	0.00	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	31.06	4.75	0.86	0.86	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	42.48	7.32	1.46	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	44.28	6.46	2.31	1.15	0.23	0.23	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	21.03	2.20	2.54	3.39	0.00	0.00	0.00
Fibroblast - Dermal, donor1	11269-116G9	69.50	11.74	0.94	0.94	0.47	0.00	1.17
Fibroblast - Dermal, donor2	11346-117G5	64.62	6.13	0.47	0.47	0.00	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	62.26	11.12	0.73	1.81	0.48	0.24	0.48
Fibroblast - Dermal, donor4	11450-119A1	38.66	6.22	1.36	0.79	0.00	0.00	0.11
Fibroblast - Dermal, donor5	11454-119A5	47.97	7.85	1.92	0.87	0.00	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	51.33	7.63	1.46	1.30	0.00	0.00	0.16
Fibroblast - Gingival, donor1	11237-116D4	68.51	6.87	1.87	1.87	0.21	0.00	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	63.14	7.07	2.36	2.10	0.79	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	69.45	11.73	1.32	1.98	0.13	0.00	0.13
Fibroblast - Gingival, donor3	11394-118C8	40.71	4.06	1.84	3.58	0.00	0.00	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	197.39	9.35	3.12	7.27	0.00	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	91.10	7.75	1.23	3.00	0.35	0.18	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	107.88	9.98	1.87	2.34	0.00	0.00	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	100.20	11.49	1.22	1.08	0.14	0.00	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	62.46	6.35	2.82	3.18	0.35	1.06	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	88.19	7.90	1.61	2.78	0.00	0.00	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	93.27	8.73	1.64	2.05	0.00	0.27	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	66.91	7.13	0.99	2.19	0.00	0.11	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	35.95	3.82	3.82	4.99	0.00	0.00	0.15
Fibroblast - Lung, donor1	11270-116H1	42.14	4.08	0.00	0.00	0.00	0.00	2.72
Fibroblast - Lung, donor2	11347-117G6	49.24	2.98	4.48	2.98	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	57.61	10.55	2.32	1.06	0.00	0.00	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	83.30	5.83	2.50	0.83	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	34.97	4.20	2.80	0.00	1.40	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	21.83	2.52	0.56	0.00	0.28	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	91.75	9.74	0.81	1.22	0.00	0.00	0.81
Fibroblast - Mammary, donor2	11620-122A9	35.95	0.00	0.00	0.00	0.00	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	53.61	5.96	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	83.21	8.15	1.75	1.36	0.00	0.00	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	50.66	8.34	2.73	1.67	0.00	0.00	0.46
Fibroblast - Periodontal Ligament, donor3	11395-118C9	52.94	4.28	1.53	1.22	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	77.85	9.16	1.53	1.53	0.38	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	107.19	7.83	1.62	1.62	0.00	0.54	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	62.05	6.03	1.74	3.71	0.46	0.00	0.58
Fibroblast - Pulmonary Artery, donor1	11250-116E8	70.85	8.73	0.66	0.77	0.00	0.22	0.55
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	82.50	6.10	0.61	0.61	0.00	0.41	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	54.79	5.35	1.34	1.34	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	88.96	9.88	0.40	0.79	0.79	0.00	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	49.02	4.76	7.94	5.75	0.00	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	41.21	3.20	2.49	2.31	0.00	0.18	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	74.30	5.12	2.17	1.97	0.59	0.59	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	43.92	4.21	8.72	6.02	0.30	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	51.17	6.05	2.37	1.40	0.32	0.11	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	50.61	5.57	10.12	5.82	0.00	0.25	0.25
Fibroblast - skin normal, donor1	11553-120C5	73.18	4.10	2.95	2.63	0.16	0.33	0.82
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	57.35	3.61	7.22	6.42	0.00	0.20	0.20
Fibroblast - skin normal, donor2	11561-120D4	64.09	4.52	2.51	2.21	0.00	0.00	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	71.63	4.84	10.58	3.93	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	50.45	4.06	1.74	2.24	0.00	0.17	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	71.97	6.15	4.10	6.67	0.17	0.17	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	35.14	2.96	9.85	2.96	0.33	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	66.58	5.86	1.92	1.81	0.11	0.11	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	111.33	10.12	1.35	1.52	0.34	0.34	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	81.39	8.31	0.63	2.20	0.16	0.00	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	465.36	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	62.75	2.61	10.46	13.94	0.00	0.00	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	67.44	5.37	1.04	1.56	0.17	0.00	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	74.43	7.55	1.56	1.30	0.00	0.00	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	79.21	7.41	1.02	2.04	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	54.35	7.66	4.59	8.42	0.00	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	73.38	8.29	7.66	5.10	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	120.67	12.84	13.69	6.28	0.00	0.00	1.43
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	67.56	8.27	44.95	10.75	0.00	0.00	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	41.78	5.94	32.19	14.61	0.00	0.00	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	72.12	10.10	18.82	7.93	0.00	0.20	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	51.02	10.04	37.27	11.10	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	41.09	5.54	43.05	19.57	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	92.42	8.84	14.15	7.96	0.00	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	55.68	5.37	8.90	3.67	0.00	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	53.20	5.42	8.13	3.57	0.00	0.00	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	55.61	3.76	5.37	4.03	0.00	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	49.68	3.84	7.06	2.48	0.00	0.00	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	52.74	7.06	4.71	1.52	0.00	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	46.56	3.25	3.46	2.85	0.00	0.00	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	50.20	6.62	8.67	3.42	0.23	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	38.86	4.73	6.10	2.74	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	35.85	3.93	6.99	2.19	0.00	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	51.71	4.14	6.50	5.61	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	45.46	4.13	8.42	2.07	0.16	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	37.98	4.47	3.80	2.68	0.00	0.00	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	54.04	6.05	8.67	6.65	0.20	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	52.42	3.73	5.60	3.05	0.00	0.00	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	59.85	5.68	8.51	2.93	0.00	0.00	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	42.77	3.85	13.53	3.54	0.00	0.00	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	48.16	3.42	12.30	4.27	0.00	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	36.18	4.87	7.64	2.99	0.00	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	48.25	4.24	9.07	3.99	0.00	0.08	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	51.25	3.88	7.35	1.84	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	43.94	4.75	6.81	3.30	0.00	0.00	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	35.51	4.96	8.19	3.00	0.12	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	37.69	4.34	9.67	4.67	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	30.86	4.85	4.85	3.97	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	33.45	3.81	6.76	4.80	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	39.06	4.70	6.65	5.35	0.16	0.00	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	29.51	6.74	9.62	4.81	0.00	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	30.89	5.50	5.21	3.60	0.00	0.00	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	37.65	4.43	4.75	2.37	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	33.45	6.08	5.17	2.43	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	34.71	4.29	6.27	2.82	0.00	0.00	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	31.40	3.73	5.49	3.51	0.00	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	39.28	2.52	4.77	3.93	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	31.39	4.91	2.78	2.69	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	32.89	4.81	2.94	5.35	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	35.19	5.36	2.91	2.75	0.00	0.00	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	41.32	4.27	2.85	1.94	0.13	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	34.70	6.51	2.98	3.25	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	38.35	2.95	5.35	4.42	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	32.46	3.73	5.48	4.61	0.00	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	25.79	0.99	10.91	9.92	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	44.72	5.01	2.37	3.96	0.00	0.00	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	44.79	3.03	4.84	5.04	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	18.55	1.78	11.18	5.08	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	106.70	6.37	12.14	3.78	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	58.55	4.47	12.63	3.85	0.00	0.00	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	81.22	6.14	15.14	4.91	0.00	0.20	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	70.10	5.32	5.01	2.19	0.00	0.00	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	72.90	4.80	2.83	0.57	0.00	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	48.89	4.61	8.30	2.31	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	56.92	2.47	0.00	2.47	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	56.09	4.25	3.09	1.93	0.00	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	36.90	8.02	8.02	1.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	43.47	5.22	12.17	1.74	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	50.12	5.53	2.93	0.98	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	58.06	3.29	4.94	4.12	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	16.66	3.33	16.66	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	47.54	4.75	6.71	2.52	0.00	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	48.05	3.92	2.61	2.61	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	51.17	3.36	8.39	3.36	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	54.39	5.41	6.68	2.23	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	56.04	5.09	4.08	2.04	0.00	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	79.35	10.44	14.62	6.26	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	58.42	8.02	5.73	1.15	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	43.21	4.44	2.66	2.07	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	59.30	6.78	5.08	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	79.11	4.56	3.73	2.07	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	57.53	5.06	3.45	1.15	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	52.68	10.54	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	49.97	3.84	5.00	3.46	0.38	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	52.81	6.85	0.98	1.96	0.00	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	59.53	4.68	3.34	1.34	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	60.49	3.85	4.24	2.31	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	50.32	2.74	8.90	1.37	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	34.79	2.48	4.97	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	42.47	3.77	6.61	2.83	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	49.49	5.43	7.24	0.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	65.11	3.05	9.66	1.53	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	50.25	5.18	5.58	1.60	0.00	0.00	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	56.24	4.93	5.43	0.99	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	57.84	10.62	10.62	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	56.01	3.50	5.25	3.50	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	42.13	4.39	6.58	0.88	0.00	0.00	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	46.62	2.54	3.39	0.85	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	60.89	9.55	5.37	2.98	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	48.04	7.28	4.37	2.91	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	316.14	19.40	1.14	1.14	1.14	1.14	3.42
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	101.04	8.32	0.42	2.49	0.42	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	154.05	9.00	0.00	2.25	0.00	0.00	3.37
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	24.42	2.85	4.12	2.22	0.63	0.63	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	33.42	6.68	1.67	1.67	0.42	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	90.63	7.43	0.70	0.46	0.12	0.12	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	92.67	6.92	0.34	0.84	0.17	0.00	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	92.82	6.83	0.46	0.91	0.46	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	94.22	9.84	0.66	0.33	0.22	0.00	0.66
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	82.10	7.52	0.43	0.21	0.00	0.00	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	84.61	7.53	0.43	0.65	0.00	0.22	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	101.50	8.97	0.50	0.75	0.00	0.00	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	87.83	6.52	0.34	0.51	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	94.83	8.33	0.64	0.96	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	59.32	6.16	0.56	0.00	0.00	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	23.37	4.33	1.30	2.16	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	34.37	5.29	0.00	7.93	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	69.49	5.64	1.06	1.06	0.00	0.71	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	17.44	5.09	2.18	1.45	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	75.36	7.52	0.87	1.05	0.17	0.00	0.35
Hepatocyte, donor1	11523-119I2	153.75	3.63	4.84	13.32	0.00	0.00	2.42
Hepatocyte, donor2	11603-120I1	156.21	4.31	4.31	8.62	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	118.41	4.29	10.43	9.20	0.00	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	131.84	11.10	36.55	6.53	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	156.95	4.54	4.89	5.07	0.00	0.00	1.40
Iris Pigment Epithelial Cells, donor1	11530-119I9	80.54	5.21	1.10	0.69	0.00	0.14	0.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	38.21	3.18	22.29	6.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	40.05	0.00	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	20.77	6.92	11.08	5.54	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	32.53	5.01	12.51	2.50	0.00	0.00	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	17.94	10.25	20.50	7.69	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	36.57	4.57	4.57	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	29.24	6.50	14.62	12.99	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	43.35	1.67	10.00	8.34	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	29.04	0.00	3.63	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	34.41	7.94	17.21	6.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	33.26	3.33	18.85	6.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	26.19	0.00	10.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	27.08	6.30	11.34	8.82	0.00	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	26.29	7.73	13.92	7.73	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	14.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	33.59	7.11	16.80	6.46	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	32.20	3.22	19.32	9.66	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	0.00	11.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	29.34	4.89	28.52	7.33	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	41.98	4.20	17.63	11.75	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	14.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	30.54	5.63	14.47	4.82	0.00	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	44.32	3.69	12.00	6.46	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	15.08	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	30.68	3.30	7.08	2.83	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	39.91	3.63	8.16	9.98	0.00	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	14.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	37.66	5.38	16.14	4.30	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	44.47	2.54	10.16	10.16	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	16.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	25.51	5.10	16.58	7.01	0.00	0.00	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	23.69	1.82	12.76	9.11	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	0.00	0.00	15.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	21.42	2.86	19.28	5.71	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	33.18	3.32	19.91	6.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	20.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	32.10	4.32	9.26	5.56	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	22.83	1.76	10.54	5.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	22.00	3.14	22.00	9.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	21.56	2.78	21.56	11.82	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	44.26	2.21	6.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	35.66	6.48	9.73	9.73	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	23.54	3.49	9.59	4.36	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	18.00	2.25	11.25	9.00	0.00	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	27.88	3.48	6.97	6.97	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	30.94	4.27	7.47	2.13	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	22.17	4.16	18.01	8.31	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	28.50	2.85	5.70	8.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	19.33	0.92	12.89	10.12	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	15.13	3.03	15.13	3.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	0.00	18.63	12.42	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	19.03	4.23	6.34	8.46	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	36.07	3.51	1.14	1.96	0.00	0.08	0.49
Keratinocyte - epidermal, donor2	11349-117G8	42.75	6.44	0.00	1.76	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	67.96	10.32	0.66	2.37	0.09	0.09	0.28
Keratinocyte - oral, donor1	11251-116E9	91.27	9.54	0.79	2.72	0.23	0.11	0.45
Keratocytes, donor1	11527-119I6	90.43	11.00	4.81	4.81	0.00	0.69	0.34
Keratocytes, donor2	11607-120I5	39.84	7.03	0.00	1.17	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	94.45	5.34	3.16	7.90	0.00	0.00	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	10.99	0.00	8.79	6.59	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	63.65	4.31	3.24	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	51.09	6.00	3.58	0.69	0.00	0.00	0.35
Lens Epithelial Cells, donor3	11690-122I7	65.19	5.95	1.51	1.41	0.00	0.20	0.50
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	167.67	15.65	0.83	1.42	0.71	0.12	1.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	130.05	13.12	0.56	1.12	0.28	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	135.53	14.64	1.57	1.57	0.00	0.16	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	146.80	12.37	0.54	1.61	0.00	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	129.85	10.09	0.95	1.89	0.00	0.00	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	134.23	10.89	0.65	1.19	0.00	0.32	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	123.53	12.72	1.23	0.82	0.41	0.41	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	132.73	10.11	0.76	1.26	0.00	0.00	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	120.20	8.45	0.70	1.69	0.14	0.14	0.70
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	119.06	11.47	0.00	1.58	0.00	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	139.01	12.21	0.78	0.58	0.39	0.19	1.55
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	127.01	16.48	1.30	0.93	0.19	0.56	1.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	134.49	12.54	0.00	0.70	0.35	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	118.07	9.54	0.24	0.95	0.00	0.00	1.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	126.50	10.99	0.27	0.96	0.27	0.27	1.10
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	102.55	10.78	0.92	0.00	0.92	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	129.06	10.91	0.31	0.62	0.00	0.00	1.25
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	129.74	11.16	0.37	0.91	0.00	0.00	1.46
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	115.19	8.89	0.33	1.97	0.00	0.33	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	137.94	10.54	0.00	1.17	0.59	0.00	1.17
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	126.21	10.70	0.50	1.00	0.00	0.00	1.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	116.39	11.15	0.00	0.00	0.48	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	141.65	7.54	0.54	1.35	0.27	0.00	2.96
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	134.27	10.29	0.61	0.61	0.00	0.00	0.61
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	116.64	8.29	0.52	1.56	0.00	0.00	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	135.06	11.10	0.42	1.68	0.42	0.42	0.84
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	122.70	10.38	0.30	1.35	0.00	0.30	1.05
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	124.51	8.25	0.00	2.06	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	112.32	10.35	0.75	1.51	0.19	0.38	1.32
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	111.12	12.41	0.53	1.17	0.42	0.21	1.17
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	110.00	7.75	0.00	1.94	0.48	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	117.10	8.93	0.33	0.66	0.00	0.00	1.65
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	106.79	9.42	0.37	1.12	0.00	0.12	1.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	116.99	8.89	0.00	1.48	0.00	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	120.08	9.39	0.49	0.99	0.49	0.25	1.73
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	116.46	10.59	0.27	1.10	0.27	0.27	0.69
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	105.18	9.65	0.64	0.32	0.00	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	143.03	11.56	0.30	2.43	0.00	0.30	2.43
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	131.15	11.34	0.42	1.12	0.14	0.00	0.98
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	110.58	11.73	0.36	1.42	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	109.07	10.67	0.00	0.48	0.48	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	121.84	11.83	0.47	1.24	0.00	0.16	0.62
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	112.45	11.82	1.07	2.15	0.36	0.00	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	102.25	8.82	0.65	0.33	0.33	0.00	1.63
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	121.95	12.71	0.47	0.71	0.24	0.00	1.18
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	121.77	8.79	0.74	1.36	0.12	0.00	0.99
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	98.61	8.20	0.00	0.77	0.00	0.00	1.54
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	109.80	9.25	0.00	1.19	0.30	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	72.51	2.27	9.06	6.80	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	66.74	4.60	3.84	9.21	0.00	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	80.90	2.23	1.48	6.68	0.00	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	62.20	4.65	3.39	5.08	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	57.67	4.92	3.52	7.03	0.00	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	70.05	3.74	2.80	4.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	52.04	4.12	2.58	9.79	0.00	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	53.53	5.95	4.76	14.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	82.79	4.75	3.85	8.60	0.00	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	82.01	4.94	2.33	6.11	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	81.93	4.95	3.15	6.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	75.60	4.88	3.66	8.40	0.00	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	53.41	6.16	2.57	11.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	87.86	5.29	2.82	6.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	99.95	4.00	4.00	4.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	64.69	4.58	2.04	10.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	77.91	7.74	5.07	8.54	0.00	0.00	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	86.35	5.10	3.78	8.12	0.00	0.19	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	73.63	4.91	1.23	13.50	0.61	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	77.47	3.26	5.71	7.34	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	78.51	7.50	1.25	7.29	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	72.87	7.85	2.24	8.97	0.28	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	73.15	4.12	4.12	11.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	79.83	5.81	2.32	10.16	0.00	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	72.64	7.77	2.39	5.38	0.00	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	93.50	6.64	3.87	6.64	0.00	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	69.28	4.60	3.18	7.42	0.35	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	65.64	8.48	1.84	5.90	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	84.04	6.91	3.45	10.36	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	74.83	4.61	3.07	9.98	0.38	0.00	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	62.27	3.40	2.83	8.49	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	82.05	4.92	4.10	7.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	65.07	4.97	4.97	8.13	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	81.87	5.75	0.72	3.59	0.00	0.00	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	80.67	0.75	1.49	8.96	0.00	0.00	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	62.43	5.57	1.11	6.32	0.00	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	80.12	5.17	5.17	7.75	0.00	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	81.35	5.14	0.86	8.56	0.00	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	79.63	7.66	3.00	9.33	0.00	0.33	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	92.31	4.83	2.41	8.45	0.00	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	88.16	4.27	2.84	8.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	71.84	8.25	4.47	10.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	67.63	4.29	2.68	8.05	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	79.46	6.73	3.37	9.43	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	77.04	5.93	5.19	11.11	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	117.46	6.98	4.65	6.98	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	82.50	4.23	4.23	3.17	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	67.63	6.00	3.20	8.80	0.40	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	68.33	5.09	2.18	8.72	0.00	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	57.49	7.67	3.07	9.96	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	60.67	3.95	5.92	8.88	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	61.16	4.70	3.76	7.53	0.94	0.94	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	65.37	7.04	5.53	8.05	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	73.45	4.51	2.70	10.81	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	51.63	3.44	1.72	5.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	66.80	5.34	4.45	10.69	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	56.70	5.08	4.30	8.99	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	62.67	4.62	0.00	4.62	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	58.64	5.19	1.56	8.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	59.07	4.38	4.38	10.06	0.00	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	73.80	5.03	3.35	5.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	64.04	7.07	2.21	10.60	0.00	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	75.21	8.10	3.47	9.64	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	67.85	6.08	1.01	5.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	74.02	3.84	4.33	11.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	65.60	5.17	4.77	9.14	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	65.02	3.65	1.82	3.04	0.61	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	56.03	3.46	2.77	8.30	0.00	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	69.92	6.08	3.42	9.12	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	72.81	4.65	3.10	4.13	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	52.60	4.23	1.21	9.07	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	76.37	6.02	3.49	6.02	0.00	0.32	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	52.78	3.73	1.60	7.46	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	56.32	6.32	3.45	6.32	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	70.45	4.63	4.11	5.66	0.00	0.00	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	55.88	4.95	1.41	7.78	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	70.94	5.67	3.97	7.94	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	68.64	5.82	2.50	7.49	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	68.91	4.70	2.35	5.48	0.00	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	71.40	4.59	2.92	6.68	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	69.70	7.90	2.32	5.58	0.46	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	78.95	2.68	2.01	9.37	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	83.94	4.81	4.81	4.81	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	78.80	6.87	4.85	6.06	0.00	0.00	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	66.08	5.51	2.75	3.67	0.92	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	62.24	3.56	1.78	3.56	0.00	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	74.08	5.13	3.42	7.98	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	89.73	10.74	1.53	4.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	93.02	5.47	1.09	3.83	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	74.84	8.02	4.45	6.24	0.00	0.00	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	105.80	7.28	4.68	4.42	0.00	0.00	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	82.23	7.96	2.65	3.98	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	70.67	6.24	10.39	6.24	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	95.27	7.52	3.19	1.82	0.00	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	182.22	15.23	1.10	0.92	1.28	0.18	0.37
Macrophage - monocyte derived, donor3	11389-118C3	103.95	12.58	1.84	1.44	1.05	0.26	1.05
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	110.45	6.37	0.00	0.53	0.00	0.53	1.06
Mallassez-derived cells, donor2	11929-125I3	135.95	10.14	1.11	1.43	0.32	0.63	0.48
Mallassez-derived cells, donor3	11930-125I4	135.23	11.54	0.42	1.39	0.28	0.28	0.42
Mammary Epithelial Cell, donor1	11273-116H4	50.62	5.08	1.79	3.49	0.00	0.10	0.20
Mammary Epithelial Cell, donor2	11350-117G9	56.75	6.95	0.58	3.19	0.29	0.00	0.29
Mammary Epithelial Cell, donor3	11422-118F9	30.43	3.24	0.50	0.25	0.00	0.00	0.50
Mast cell - stimulated, donor1	11487-119E2	208.80	10.85	3.39	2.03	0.00	0.00	2.03
Mast cell, donor1	11563-120D6	153.34	7.57	4.87	3.24	0.00	0.00	0.43
Mast cell, donor2	11565-120D8	22.29	5.35	9.21	3.86	0.30	0.00	0.00
Mast cell, donor3	11566-120D9	19.14	4.28	12.83	4.05	0.23	0.23	0.00
Mast cell, donor4	11567-120E1	19.50	3.55	10.81	3.90	0.00	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	121.10	16.08	9.54	6.99	0.00	0.00	0.44
Mast cell, expanded and stimulated, donor8	11942-126A7	72.96	4.67	4.67	4.67	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	167.72	12.85	7.80	5.39	0.00	0.00	0.46
Mast cell, expanded, donor8	11941-126A6	54.23	6.69	8.54	5.36	0.00	0.00	0.17
Melanocyte - dark, donor1	11502-119F8	98.50	8.56	0.50	0.99	0.10	0.00	0.80
Melanocyte - dark, donor2	11582-120F7	110.05	7.61	0.35	0.69	0.00	0.00	0.35
Melanocyte - dark, donor3	11663-122F7	45.93	4.49	1.45	2.03	0.07	0.07	0.43
Melanocyte - light, donor1	11274-116H5	25.15	1.65	1.18	0.94	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	49.14	5.46	0.68	1.36	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	27.75	4.34	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	48.00	5.83	0.42	2.71	0.00	0.00	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	75.84	6.19	0.54	3.23	0.00	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	67.23	4.82	2.68	8.04	0.00	0.00	0.00
Meningeal Cells, donor1	11493-119E8	69.97	6.70	1.49	1.12	0.00	0.00	0.00
Meningeal Cells, donor2	11573-120E7	79.67	4.40	1.76	0.88	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	53.30	6.11	1.14	0.65	0.08	0.00	0.41
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	77.56	13.69	1.14	0.00	0.29	0.00	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	30.49	4.53	2.01	2.21	0.10	0.00	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	7.88	0.00	1.31	2.63	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	22.24	6.54	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	108.36	6.46	0.72	2.15	0.00	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	64.59	5.72	1.27	0.85	0.21	0.42	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	76.90	7.04	2.51	1.51	0.00	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	60.21	8.57	1.54	0.88	0.22	0.00	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	43.84	6.58	2.92	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	41.13	7.16	0.82	0.20	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	53.46	6.51	2.22	1.25	0.42	0.28	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	30.11	2.60	1.12	1.12	0.00	0.74	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	51.58	4.34	0.53	1.45	0.00	0.00	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	17.51	2.67	1.19	2.08	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	14.01	0.00	0.00	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	51.87	5.12	3.20	1.92	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	122.99	13.82	0.35	0.35	0.00	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	58.79	5.94	1.56	0.63	0.31	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	73.29	7.98	0.00	0.00	0.00	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	119.33	10.08	1.86	2.92	2.39	2.92	0.80
Mesothelial Cells, donor2	12156-128G5	94.09	10.01	1.50	0.00	2.00	3.00	0.00
Mesothelial Cells, donor3	11402-118D7	70.89	7.52	1.88	1.88	2.67	2.53	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	40.51	5.40	2.70	2.70	0.00	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	90.63	10.59	1.72	0.99	0.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	107.48	12.37	1.47	1.18	0.59	0.29	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	0.00	3.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	77.49	7.44	0.62	1.24	0.31	0.00	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	89.61	8.09	1.87	0.62	1.24	0.62	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	23.16	2.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	95.35	11.01	0.75	1.25	0.50	0.50	1.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	82.39	11.17	0.47	0.00	0.93	0.47	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	81.08	9.14	1.22	1.02	0.41	0.41	0.81
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	78.40	6.34	1.19	0.79	1.19	2.77	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	0.00	0.00	8.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	81.41	6.19	2.65	0.00	0.88	3.54	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	115.88	12.92	1.14	1.14	1.14	0.76	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	19.74	3.95	0.00	0.00	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	71.52	10.61	0.64	0.64	0.42	1.27	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	60.77	7.37	1.84	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	47.39	5.66	0.60	0.60	1.19	2.38	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	36.89	8.38	1.68	0.00	1.68	3.35	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	91.83	9.28	0.25	0.50	1.51	1.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	119.78	10.70	1.19	0.71	3.57	4.04	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	60.26	12.16	0.00	0.55	1.66	2.76	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	127.33	13.35	0.92	0.00	3.22	5.30	0.92
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	119.47	11.78	1.05	1.47	4.21	6.31	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	131.27	8.97	0.20	0.82	3.67	7.13	0.82
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	110.92	8.37	0.43	0.43	3.00	4.51	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	150.05	11.34	0.67	0.89	2.45	4.22	0.89
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	105.35	7.67	0.44	0.66	3.50	8.32	0.88
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	126.74	10.14	0.00	0.51	3.04	1.52	1.52
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	53.02	11.60	0.00	3.31	0.00	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	129.10	11.14	0.27	0.82	4.89	9.51	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	184.10	14.12	1.18	2.06	2.65	5.00	1.47
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	82.86	7.63	0.00	2.18	1.09	2.18	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	153.78	13.46	0.48	0.96	2.40	6.25	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	235.73	14.81	0.40	0.40	4.40	7.20	2.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	145.35	16.45	0.00	1.37	2.74	6.86	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	215.25	14.52	0.50	1.00	2.00	8.51	3.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	161.68	53.89	0.00	0.00	0.00	26.95	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	126.39	18.35	0.00	2.04	8.15	4.08	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	390.19	21.46	0.88	0.44	7.44	10.51	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	192.04	22.07	2.21	1.10	3.31	1.10	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	233.10	12.81	0.64	2.56	3.20	7.04	1.92
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	424.44	21.32	0.74	0.99	6.20	14.63	1.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	219.90	9.05	1.39	0.00	0.70	2.09	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	289.49	8.84	0.00	0.00	2.21	2.21	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	529.91	25.64	0.68	2.74	7.18	10.26	2.05
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	260.38	16.19	1.31	0.88	3.06	3.50	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	210.22	15.62	2.13	1.42	2.49	3.55	1.78
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	685.95	33.11	0.28	0.56	13.75	11.22	5.61
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	423.53	23.28	0.00	0.83	4.99	5.40	4.16
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	249.42	15.15	1.75	3.50	1.75	2.91	2.91
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	470.30	28.05	1.81	2.11	3.32	7.84	3.02
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	571.41	25.04	2.09	0.83	7.10	6.68	4.17
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	194.91	14.44	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	410.06	24.01	0.92	1.85	9.24	13.85	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	519.60	31.30	0.57	1.71	6.83	5.69	4.55
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	350.15	20.59	1.38	0.83	4.28	7.88	5.53
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	547.84	33.69	1.04	1.55	8.55	14.25	4.41
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	496.75	25.31	1.29	1.29	3.86	8.15	1.72
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	220.41	11.43	0.00	1.91	0.64	7.62	1.27
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	319.47	24.55	0.80	0.80	5.60	9.87	2.40
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	374.16	22.75	1.20	0.90	4.79	3.59	2.39
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	235.05	18.79	0.71	0.99	3.67	5.51	2.40
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	592.12	30.26	0.32	0.96	13.06	17.84	3.19
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	782.14	30.74	1.33	1.33	8.18	8.85	8.40
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	303.74	19.34	0.38	1.90	5.69	4.93	2.28
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	496.62	26.42	0.28	0.00	12.50	18.47	4.83
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	786.08	36.38	0.98	1.23	9.09	9.09	3.20
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	167.48	14.34	1.30	1.96	3.26	3.26	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	269.62	30.28	0.59	0.29	5.59	7.94	2.35
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	517.55	29.99	0.58	1.44	6.05	4.61	2.88
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	140.54	9.89	2.47	1.24	0.82	3.30	1.24
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	220.95	20.84	1.19	0.89	4.47	5.36	1.49
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	75.34	11.30	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	71.29	7.13	1.78	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	84.11	5.91	2.63	1.31	0.99	0.33	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	70.48	5.26	0.00	1.05	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	31.63	4.35	1.38	1.38	0.20	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	32.60	0.93	0.93	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	23.28	3.76	1.13	0.38	0.38	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	50.07	8.52	0.53	0.00	0.00	0.00	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	57.57	6.67	1.02	0.79	0.45	0.23	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	40.52	5.89	0.00	0.74	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	56.43	5.13	2.56	0.00	0.37	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	51.33	6.22	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	92.99	10.69	0.53	0.00	0.53	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	57.96	3.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	70.70	3.03	0.00	1.01	0.00	3.03	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	69.99	9.70	0.42	0.84	1.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	129.38	12.26	1.36	2.72	2.72	2.72	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	143.69	16.53	0.64	0.00	4.45	5.09	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	228.37	15.39	2.43	0.00	3.24	9.72	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	111.77	12.08	1.51	6.04	1.51	3.02	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	137.04	51.39	17.13	17.13	0.00	17.13	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	215.32	39.15	3.26	19.57	0.00	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	503.76	38.02	0.00	4.75	9.50	4.75	14.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	138.04	0.00	0.00	12.55	0.00	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	85.96	7.97	1.08	1.29	0.65	0.43	0.86
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	30.31	1.57	2.09	2.09	0.52	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	26.03	2.00	2.67	2.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	15.44	2.50	1.25	1.25	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	84.80	17.11	3.61	1.71	0.00	0.00	0.76
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	47.88	7.98	1.60	3.19	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	11.56	1.36	2.72	3.40	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	36.75	9.19	1.84	1.84	0.00	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	29.72	4.19	4.19	2.93	0.00	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	46.95	9.99	0.93	1.39	0.46	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	31.08	3.24	2.70	1.62	0.00	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	39.52	3.15	3.78	2.73	0.00	0.21	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	178.16	33.40	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	36.23	2.98	3.97	4.96	1.49	0.99	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	48.99	7.58	1.62	3.52	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	34.00	4.31	1.36	2.27	0.68	0.45	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	27.60	6.70	1.31	2.45	0.49	0.16	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	46.29	4.74	1.82	4.56	0.18	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	29.70	4.24	3.18	3.18	0.00	0.53	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	10.81	3.00	2.40	3.00	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	79.42	9.19	4.27	4.59	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	25.04	3.25	1.46	4.07	0.00	0.81	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	31.57	3.35	1.94	2.29	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	19.69	4.92	4.92	1.41	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	22.99	4.60	1.38	5.06	0.00	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	30.85	3.21	0.96	4.82	0.00	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	88.29	15.86	1.03	5.52	0.34	2.07	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	101.14	17.70	7.59	10.11	0.00	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	25.62	5.79	1.34	4.90	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	22.86	3.81	0.85	2.54	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	25.87	5.22	3.32	4.03	0.24	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	28.76	3.00	3.43	3.43	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	126.39	9.03	9.03	9.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	26.99	4.00	5.33	3.00	0.33	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	10.82	2.25	3.16	2.25	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	27.38	5.16	1.59	1.98	0.00	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	19.50	3.71	2.79	5.57	0.00	0.93	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	37.46	6.43	1.89	3.03	0.38	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	25.74	0.98	1.63	3.58	0.33	0.33	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	14.82	2.18	1.74	6.97	0.00	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	23.52	2.71	1.36	2.26	0.00	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	17.64	2.65	3.53	1.76	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	31.91	2.66	3.99	7.31	0.00	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	23.81	2.98	3.97	1.98	0.99	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	13.02	2.68	3.06	4.21	0.00	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	43.85	6.65	5.14	5.14	0.00	0.00	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	21.22	2.65	2.43	1.55	0.22	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	11.52	2.03	2.71	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	91.97	0.00	0.00	5.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	30.48	5.49	2.44	6.10	0.00	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	16.37	1.57	3.46	3.78	0.31	0.94	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	13.92	2.12	5.15	4.54	0.00	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	22.15	6.33	2.37	1.58	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	43.08	10.20	3.40	3.40	0.00	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	55.64	5.06	5.06	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	69.44	6.09	1.12	1.61	0.25	1.12	0.37
Myoblast, donor2	11322-117D8	44.30	5.37	0.96	2.30	0.38	0.00	0.19
Myoblast, donor3	11398-118D3	42.88	3.70	1.85	0.84	0.00	0.00	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	199.93	8.61	6.86	5.11	0.15	0.00	1.61
Natural Killer Cells, donor1	11230-116C6	119.62	4.00	13.22	10.15	0.00	0.00	0.62
Natural Killer Cells, donor2	11311-117C6	61.82	4.22	7.84	7.84	0.00	0.00	0.30
Natural Killer Cells, donor3	11387-118C1	79.51	3.50	8.47	5.89	0.18	0.18	0.74
Neural stem cells, donor1	11275-116H6	44.28	5.44	8.71	5.44	0.00	0.36	0.00
Neural stem cells, donor2	11352-117H2	30.81	3.85	15.41	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	33.00	7.97	10.24	6.83	0.00	0.00	0.00
Neurons, donor2	11574-120E8	31.70	2.64	16.95	2.42	0.00	0.00	0.00
Neurons, donor3	11655-122E8	18.09	3.29	12.33	1.64	0.00	0.00	0.82
Neutrophils, donor1	11233-116C9	31.55	1.86	2.78	7.42	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	23.19	0.00	0.00	2.90	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	29.32	0.61	9.16	9.16	0.61	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	28.26	2.85	1.42	2.02	0.00	0.00	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	25.72	2.60	1.63	1.30	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	55.75	5.41	2.21	1.40	0.20	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	27.12	3.44	2.62	5.23	0.00	0.28	0.14
Olfactory epithelial cells, donor2	11934-125I8	42.84	6.08	2.17	6.80	0.14	0.29	0.29
Olfactory epithelial cells, donor3	11935-125I9	35.30	4.43	2.16	5.45	0.34	0.00	0.23
Olfactory epithelial cells, donor4	11936-126A1	37.89	4.77	3.02	4.58	0.39	0.19	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	86.66	8.43	1.20	0.60	0.00	0.00	1.81
Osteoblast - differentiated, donor1	11276-116H7	18.93	2.55	0.43	1.70	0.21	0.85	0.00
Osteoblast - differentiated, donor2	11353-117H3	12.57	8.00	0.00	2.29	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	19.86	4.34	3.10	3.10	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	92.83	8.99	0.78	0.78	0.78	0.00	0.98
Osteoblast, donor2	11354-117H4	75.85	10.53	0.70	1.40	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	60.07	8.18	0.36	0.53	0.18	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	111.11	10.70	1.60	2.53	0.34	0.67	0.59
Pericytes, donor1	11491-119E6	14.46	1.67	1.22	1.00	0.11	0.00	0.11
Pericytes, donor2	11571-120E5	19.92	1.81	3.17	1.58	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	60.22	5.29	1.22	1.63	0.00	0.00	0.20
Perineurial Cells, donor1	11499-119F5	80.36	9.72	1.13	1.13	0.11	0.00	1.24
Perineurial Cells, donor2	11579-120F4	124.77	9.75	0.64	0.74	0.00	0.00	1.47
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	116.02	4.14	14.66	2.87	0.00	0.00	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	88.15	2.94	7.35	5.39	0.00	0.00	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	88.91	4.01	9.32	4.79	0.13	0.00	1.16
Placental Epithelial Cells, donor1	11278-116H9	28.22	3.59	3.83	2.87	0.00	2.87	0.00
Placental Epithelial Cells, donor2	11355-117H5	29.94	3.33	1.11	2.22	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	21.01	3.73	2.16	5.89	0.00	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	14.87	3.16	0.32	0.95	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	12.19	1.88	1.88	1.31	0.56	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	14.49	1.96	5.61	3.13	0.00	0.00	0.13
Preadipocyte - breast, donor2	11328-117E5	14.86	1.58	1.58	2.25	0.00	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	23.12	2.13	2.45	1.39	0.00	0.00	0.11
Preadipocyte - omental, donor2	11329-117E6	20.51	1.31	1.31	0.00	0.44	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	19.05	2.44	3.15	1.72	0.00	0.14	0.00
Preadipocyte - perirenal, donor1	11469-119C2	23.62	0.00	0.98	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	66.03	7.37	0.92	0.92	0.92	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	138.12	15.05	1.42	2.66	0.18	0.71	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	112.39	14.81	1.36	1.53	0.17	0.85	1.19
Preadipocyte - visceral, donor1	11280-116I2	127.33	9.78	1.49	1.58	0.00	0.37	0.47
Preadipocyte - visceral, donor2	11357-117H7	109.52	11.04	3.68	4.14	0.00	0.92	0.92
Preadipocyte - visceral, donor3	11429-118G7	95.50	11.08	1.78	1.36	0.21	0.10	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	81.61	2.11	4.83	3.47	0.00	0.00	0.75
Prostate Epithelial Cells, donor2	11331-117E8	36.16	4.06	2.30	3.25	0.14	0.27	0.27
Prostate Epithelial Cells, donor3	11404-118D9	6.49	0.31	3.37	5.51	0.00	0.00	0.00
Prostate Stromal Cells, donor1	11254-116F3	142.49	9.23	1.71	1.48	0.23	0.34	2.62
Prostate Stromal Cells, donor2	11332-117E9	129.27	14.88	0.90	1.43	1.26	1.26	0.18
Prostate Stromal Cells, donor3	11405-118E1	66.53	9.38	1.67	1.88	1.88	1.56	0.94
Renal Cortical Epithelial Cells, donor1	11516-119H4	49.27	8.03	0.73	0.73	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	58.50	9.01	0.55	1.18	0.00	0.14	0.14
Renal Epithelial Cells, donor1	11517-119H5	39.56	3.04	0.00	1.01	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	44.10	7.11	2.13	1.42	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	88.08	6.78	1.16	1.06	0.32	0.00	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	46.30	4.09	0.68	2.04	0.00	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	75.74	7.28	0.67	0.27	0.00	0.00	1.21
Renal Glomerular Endothelial Cells, donor3	11675-122H1	81.92	8.88	0.44	1.11	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	23.96	3.33	0.00	0.00	0.00	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	51.72	4.84	1.54	0.88	0.00	0.00	0.44
Renal Mesangial Cells, donor2	11598-120H5	49.53	7.52	1.25	0.63	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	28.85	3.33	1.11	1.11	0.00	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	133.67	10.20	1.34	0.54	0.00	0.27	0.81
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	70.84	11.39	1.27	1.69	0.00	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	70.58	10.41	0.77	0.77	0.00	0.00	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	80.12	7.78	1.56	0.52	0.00	0.00	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	36.10	3.70	3.98	1.14	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	22.64	8.23	2.06	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	29.61	3.76	1.76	2.01	0.00	0.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	99.43	5.21	9.76	5.48	0.00	0.53	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	112.57	5.36	11.61	3.57	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	230.61	9.36	12.66	4.95	0.00	0.00	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	113.11	11.60	14.50	3.48	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	131.20	7.41	9.23	2.47	0.00	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	100.50	9.24	7.25	2.88	0.00	0.00	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	179.13	12.49	9.48	3.35	0.00	0.00	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	194.62	10.92	5.58	1.61	0.25	0.12	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	111.53	8.62	5.71	2.10	0.12	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	119.73	10.86	7.63	4.62	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	99.40	6.57	7.26	2.88	0.00	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	110.28	11.04	8.47	4.24	0.00	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	161.81	12.18	5.55	1.61	0.00	0.00	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	121.79	5.59	6.31	2.44	0.00	0.00	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	112.47	9.98	5.79	3.54	0.00	0.00	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	121.26	8.19	7.08	3.10	0.22	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	82.78	5.16	8.60	2.29	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	101.27	9.50	6.61	2.98	0.09	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	151.83	8.64	8.64	1.88	0.00	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	109.88	7.43	8.76	3.45	0.00	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	104.64	8.66	7.11	2.92	0.00	0.00	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	126.99	7.64	8.02	3.06	0.00	0.00	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	113.74	7.48	4.91	1.39	0.00	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	99.51	7.29	9.53	2.80	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	132.10	8.89	7.69	3.25	0.17	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	102.47	6.56	7.29	3.10	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	98.23	7.97	6.25	3.31	0.00	0.00	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	136.74	9.27	6.04	3.09	0.00	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	128.79	8.26	6.84	1.18	0.00	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	112.90	10.91	5.16	3.57	0.00	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	133.76	8.42	8.18	2.57	0.00	0.00	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	114.25	8.09	7.05	1.24	0.00	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	108.39	9.29	7.52	1.99	0.00	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	102.77	9.40	5.64	4.39	0.00	0.00	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	117.76	6.33	7.00	2.56	0.00	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	95.88	10.39	9.37	3.07	0.00	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	101.60	11.37	5.40	4.05	0.19	0.00	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	112.96	6.53	5.50	3.61	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	92.45	9.60	7.82	5.08	0.00	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	110.32	11.98	8.70	4.27	0.16	0.00	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	119.81	6.14	6.82	3.75	0.00	0.00	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	137.45	11.39	7.10	3.26	0.00	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	102.36	8.00	7.46	4.26	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	77.15	7.33	9.82	3.04	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	120.24	11.67	3.57	2.62	0.00	0.00	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	107.22	8.87	13.30	5.44	0.00	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	102.65	6.87	11.68	3.30	0.00	0.09	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	97.47	8.38	8.38	2.45	0.00	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	76.16	6.95	8.16	4.84	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	145.88	10.16	9.55	2.69	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	219.93	10.48	33.48	9.61	0.00	0.00	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	129.60	7.30	13.99	1.22	0.00	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	146.48	7.84	7.53	3.62	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	121.69	7.92	9.27	6.11	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	130.00	9.59	15.88	5.99	0.00	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	141.10	5.08	14.76	4.96	0.00	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	154.32	8.11	13.66	6.62	0.21	0.00	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	155.05	10.22	18.63	10.82	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	50.97	6.96	1.32	0.56	0.00	0.00	0.38
Schwann Cells, donor2	11578-120F3	64.65	6.80	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	62.66	10.52	0.66	0.66	0.00	0.00	0.00
Sebocyte, donor1	11220-116B5	71.21	4.38	1.10	1.10	0.55	0.00	1.64
Sebocyte, donor2	11301-117B5	39.98	5.51	2.76	3.22	0.00	0.00	0.46
Sebocyte, donor3	11378-118B1	42.05	5.36	1.03	2.68	0.21	0.21	0.00
Sertoli Cells, donor1	11255-116F4	76.20	6.63	1.66	1.66	0.00	0.00	1.66
Sertoli Cells, donor2	11333-117F1	39.54	2.82	2.82	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	67.83	5.72	5.81	4.13	0.18	0.00	0.26
Skeletal Muscle Cells, donor2	11358-117H8	23.85	1.45	2.17	1.45	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	68.56	6.69	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	95.36	12.10	1.89	1.10	0.00	0.00	0.47
Skeletal Muscle Cells, donor5	11455-119A6	84.73	9.66	1.78	1.04	0.15	0.00	0.00
Skeletal Muscle Cells, donor6	11459-119B1	77.41	9.85	1.39	1.08	0.00	0.15	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	84.17	11.72	2.02	2.02	0.13	0.13	0.76
Skeletal Muscle Satellite Cells, donor2	11321-117D7	51.65	12.56	1.43	1.57	0.00	0.00	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	74.21	12.00	1.59	0.99	0.00	0.00	0.79
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	53.75	5.56	3.29	1.10	0.08	0.25	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	51.39	10.86	0.72	2.90	1.45	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	54.63	8.12	0.55	1.51	0.14	0.00	0.14
Skin - palm, donor1	10286-104F7	24.17	5.37	16.12	18.80	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	23.79	2.88	0.72	2.31	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	47.44	4.09	15.54	24.54	0.00	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	38.56	3.76	0.78	2.73	0.00	0.00	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	38.09	2.50	1.11	2.36	0.42	0.14	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	16.60	1.41	1.55	3.66	0.00	0.00	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	59.63	5.92	20.51	30.24	0.00	0.42	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	15.81	1.35	1.95	4.72	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	43.82	4.63	1.23	0.62	0.93	0.00	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	26.90	1.78	5.78	4.89	0.22	0.00	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	58.19	6.47	0.59	1.18	0.00	0.59	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	146.52	7.96	0.44	1.33	0.66	0.66	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	56.70	5.91	0.00	0.39	0.39	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	50.99	10.82	0.77	0.77	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	42.03	3.00	2.00	2.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	46.84	7.32	1.06	0.67	0.27	0.00	0.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	64.72	11.08	2.22	1.33	0.44	0.22	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	73.23	8.71	0.77	1.41	0.64	0.13	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	83.68	9.77	2.28	2.28	0.00	0.00	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	81.51	7.09	1.77	0.30	0.00	0.00	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	60.08	7.55	0.85	1.28	0.57	0.28	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	40.34	7.48	0.98	0.16	0.00	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	32.57	3.35	3.04	2.44	0.00	0.00	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	59.60	7.83	1.01	2.02	0.25	0.00	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	42.84	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	72.96	8.58	1.43	1.43	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	70.64	8.11	2.06	0.74	0.15	0.29	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	45.85	8.39	0.86	0.43	0.22	0.00	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	58.99	8.82	1.57	1.15	0.10	0.00	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	60.48	8.51	0.15	1.39	0.00	0.15	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	54.97	9.70	2.16	0.00	0.00	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	66.64	7.77	0.60	0.30	0.30	0.90	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	39.26	4.44	0.68	0.68	0.00	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	40.13	4.71	2.04	1.02	0.08	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	77.19	4.33	2.01	3.62	0.91	0.70	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	349.29	14.34	1.59	6.14	0.68	1.59	6.60
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	52.53	4.23	1.81	1.21	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	101.20	9.27	2.65	1.59	0.00	0.00	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	122.51	6.26	2.26	1.60	0.40	0.13	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	67.87	7.26	2.13	3.13	0.00	0.00	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	44.90	3.80	1.52	2.03	0.76	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	67.24	7.84	0.90	1.21	0.45	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	63.76	9.00	1.50	6.00	0.00	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	18.09	3.88	0.00	1.29	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	43.72	6.98	0.93	1.86	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	67.65	5.05	0.50	2.52	0.50	0.00	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	146.36	10.03	0.63	2.82	0.63	0.31	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	60.47	7.67	0.59	0.29	0.29	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	88.47	9.08	0.42	0.75	0.00	0.00	0.67
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	34.57	5.14	0.93	1.87	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	57.42	8.49	0.00	0.43	0.58	0.14	0.43
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	73.68	11.98	0.25	1.78	1.02	0.25	0.76
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	67.69	6.77	0.56	0.75	0.00	0.19	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	80.35	9.08	1.12	1.12	0.42	0.00	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	77.17	9.05	0.59	0.34	0.08	0.25	0.59
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	20.95	1.90	0.48	1.43	0.48	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	59.21	8.07	0.49	1.22	0.24	0.24	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	85.51	5.52	1.77	0.88	0.66	0.66	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	112.64	12.58	1.46	1.17	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	15.16	1.94	3.89	5.05	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	49.98	4.50	1.06	1.59	0.53	0.26	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	61.00	4.84	4.46	5.21	0.74	0.00	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	48.51	4.67	3.23	1.80	0.72	0.00	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	44.57	5.96	0.57	0.57	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	45.29	2.76	2.76	1.97	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	60.95	6.35	3.05	4.06	0.25	0.25	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	31.95	4.79	10.78	4.79	0.00	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	46.82	2.51	3.34	3.76	0.42	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	27.04	4.13	3.67	2.75	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	90.22	3.37	1.18	0.67	1.35	2.36	0.50
Synoviocyte, donor2	11368-117I9	65.71	6.37	2.35	5.70	0.50	0.17	0.84
Synoviocyte, donor3	11440-118H9	43.12	8.49	3.57	2.90	0.00	0.45	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	44.31	7.86	1.43	2.14	0.00	0.00	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	11.89	5.95	1.98	3.96	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	18.29	3.94	1.85	2.08	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	39.78	4.87	0.36	1.00	0.00	0.22	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	49.48	6.96	1.16	0.77	0.39	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	44.09	4.01	0.00	1.15	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	91.04	4.92	7.26	6.89	0.00	0.12	0.25
Urethra, donor2	10319-105A4	41.36	7.19	12.59	10.79	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	50.48	5.84	0.27	1.06	0.00	0.00	0.27
Urothelial Cells, donor2	11600-120H7	40.86	6.01	0.80	1.20	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	30.48	2.29	0.69	2.06	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	63.53	6.46	1.11	0.45	0.22	0.00	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	151.26	4.45	8.90	4.45	0.00	0.00	4.45
Whole blood (ribopure), donor090309, donation2	12180-129A2	164.41	10.01	11.44	2.86	0.00	0.00	7.15
Whole blood (ribopure), donor090309, donation3	12181-129A3	64.34	2.74	5.48	5.48	0.00	0.00	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	116.73	5.17	15.15	3.79	0.00	0.00	2.41
Whole blood (ribopure), donor090325, donation2	12177-128I8	111.56	5.23	11.04	5.23	0.58	0.00	3.49
Whole blood (ribopure), donor090612, donation1	12182-129A4	127.03	2.08	14.58	4.16	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	132.16	7.34	9.18	1.84	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	75.77	6.39	9.13	1.83	0.00	0.00	4.56
Wilms' tumor cell line:G-401	10809-111A8	78.58	9.62	4.69	2.71	0.37	0.12	0.25
Wilms' tumor cell line:HFWT	10597-108E3	9.68	4.40	12.32	11.44	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	91.90	4.75	1.96	3.91	0.28	0.00	0.56
achilles tendon, donor2	10292-104G4	45.46	4.13	4.13	2.07	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	305.95	10.96	8.16	2.80	0.00	0.00	1.02
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	260.73	13.00	10.45	3.25	0.00	0.00	1.86
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	136.16	11.04	17.69	3.92	0.00	0.00	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	156.19	14.69	27.21	5.17	0.00	0.00	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	127.05	13.49	2.81	1.97	0.00	0.00	1.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	183.78	13.32	6.34	2.11	0.00	0.00	1.06
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	91.19	4.08	13.07	10.07	0.27	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	82.40	10.13	0.44	1.76	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	177.64	10.21	11.43	2.86	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	267.15	15.53	8.15	3.49	0.00	0.00	3.11
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	52.44	7.91	2.58	1.29	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	42.91	3.90	3.90	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	145.24	12.32	7.90	3.95	0.00	0.00	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	154.31	6.47	9.58	4.40	0.00	0.00	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	129.46	8.77	9.94	4.38	0.00	0.00	1.75
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	55.77	6.04	12.08	5.11	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	157.51	8.23	11.10	6.17	0.00	0.00	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	60.16	7.06	2.76	0.92	0.00	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	234.26	11.52	8.11	2.99	0.00	0.00	2.56
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	265.08	14.56	3.64	3.34	0.00	0.00	1.21
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	273.20	13.24	3.85	1.20	0.00	0.00	1.93
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	62.37	7.80	4.23	1.56	0.00	0.00	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	83.39	9.34	5.34	4.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	126.36	13.01	9.29	3.72	0.00	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	90.78	10.17	4.90	6.03	0.00	0.00	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	37.51	6.54	13.52	5.23	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	97.47	3.75	22.49	13.12	0.00	0.00	3.75
adenocarcinoma cell line:IM95m	10796-110I4	85.96	7.30	5.89	6.12	0.00	0.00	0.71
adipose tissue, adult, pool1	10010-101C1	32.11	3.57	3.10	1.86	0.16	0.00	0.00
adipose, donor1	10184-103D4	66.85	18.77	23.46	4.69	0.00	0.00	0.00
adipose, donor2	10185-103D5	38.52	1.22	33.66	12.57	0.00	0.00	0.00
adipose, donor3	10186-103D6	43.84	4.63	28.05	10.89	0.00	0.00	0.27
adipose, donor4	10187-103D7	47.67	7.80	16.47	2.60	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	27.30	6.63	7.10	2.21	0.00	0.00	0.32
adrenal gland, adult, pool1	10081-102A9	61.84	18.19	10.91	7.28	0.00	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	220.39	8.80	30.82	16.54	0.13	0.00	2.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	90.40	12.15	6.07	1.79	0.00	0.00	0.36
amniotic membrane cells, donor1	12235-129G3	22.49	2.78	6.03	5.80	0.00	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	46.66	6.42	1.01	10.82	0.00	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	10.31	2.06	3.83	5.01	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	7.11	1.19	15.42	5.93	0.00	1.19	0.00
amygdala, adult, donor10252	10151-102I7	20.07	4.06	18.86	9.53	0.00	0.00	0.00
amygdala, newborn, donor10223	10360-105E9	18.08	1.61	13.56	7.75	0.32	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	121.35	6.24	10.31	7.89	0.13	0.38	0.64
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	390.06	12.13	3.31	8.16	0.22	0.00	8.82
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	42.09	5.01	20.38	8.02	0.33	0.00	0.00
aorta, adult, pool1	10052-101G7	18.83	4.31	4.12	3.53	0.00	0.00	0.00
appendix, adult	10189-103D9	99.36	4.66	21.35	8.93	0.00	0.00	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	50.21	7.57	15.82	3.44	0.00	0.00	0.00
artery, adult	10190-103E1	24.46	2.72	1.36	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	120.09	13.91	4.06	1.59	0.00	0.00	0.43
b cell line:RPMI1788	10427-106D4	156.14	7.29	13.68	4.61	0.15	0.15	3.12
basal cell carcinoma cell line:TE 354.T	10702-109G9	93.78	9.71	1.11	2.77	0.55	4.16	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	81.67	4.96	1.19	1.09	0.00	0.20	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	84.36	2.01	12.05	12.05	0.00	0.00	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	82.21	2.80	3.36	6.15	0.00	0.00	1.12
bladder, adult, pool1	10011-101C2	24.44	4.56	3.69	4.45	0.11	0.00	0.00
blood, adult, pool1	10053-101G8	104.09	0.00	2.21	4.43	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	81.35	5.99	3.43	0.86	0.86	1.71	0.00
bone marrow, adult	10192-103E3	79.63	13.50	8.10	4.72	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	10.25	2.05	9.23	4.10	1.03	0.00	0.00
brain, adult, pool1	10012-101C3	12.25	2.00	12.25	3.67	0.00	0.00	0.00
brain, fetal, pool1	10085-102B4	8.01	2.67	34.73	13.36	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	70.70	6.28	11.89	46.25	0.00	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	42.44	3.25	30.33	44.44	0.00	0.00	0.12
breast, adult, donor1	10080-102A8	22.10	3.79	3.16	2.53	0.00	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	103.66	7.24	2.41	2.16	0.00	0.00	0.89
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	98.33	10.20	8.35	4.33	0.00	0.00	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	497.50	69.76	15.89	5.76	0.46	0.23	0.92
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	78.19	3.63	2.18	3.39	0.00	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	82.28	6.11	16.93	0.94	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	68.36	5.03	4.59	4.81	0.11	0.00	1.09
carcinoid cell line:SK-PN-DW	10719-109I8	21.23	3.80	15.53	1.90	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	72.13	4.53	21.03	10.11	0.00	0.00	0.27
caudate nucleus - adult, donor10196	10177-103C6	14.97	2.30	20.72	5.76	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	22.59	2.01	31.29	7.86	0.17	0.00	0.00
caudate nucleus, adult, donor10258	10379-105H1	7.64	0.76	25.22	6.88	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	20.14	1.83	20.14	6.23	0.00	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	2.91	0.00	32.05	5.83	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	8.54	1.71	60.21	8.54	0.00	0.00	0.00
cerebellum, adult, pool1	10083-102B2	8.28	1.38	14.83	4.83	0.00	0.00	0.34
cerebellum, newborn, donor10223	10357-105E6	15.78	3.32	57.29	9.96	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	19.67	3.03	7.56	6.81	0.00	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	29.24	1.46	2.92	2.19	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	50.90	3.02	2.88	4.31	0.00	0.00	0.29
cervical cancer cell line:ME-180	10553-107I4	144.50	2.49	1.66	2.98	0.00	0.00	0.50
cervix, adult, pool1	10013-101C4	34.65	4.93	13.86	7.45	0.00	0.10	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	132.09	9.34	4.74	2.79	0.00	0.00	0.70
chondrosarcoma cell line:SW 1353	10700-109G7	26.13	2.61	7.84	2.61	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	109.36	6.84	8.58	5.84	0.00	0.12	0.75
choriocarcinoma cell line:SCH	10785-110H2	69.25	7.64	8.99	12.20	0.00	0.00	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	4.98	1.66	11.62	6.88	0.00	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	56.13	4.56	1.99	5.13	0.28	0.00	0.28
chorionic membrane cells, donor2	12239-129G7	83.42	9.15	1.69	1.99	0.20	0.30	0.70
chorionic membrane cells, donor3	12240-129G8	70.88	2.75	2.75	4.40	0.00	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	323.14	11.11	5.05	3.03	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	91.25	8.64	1.15	1.54	0.19	0.00	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	74.76	5.70	5.07	2.75	0.00	0.00	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	43.14	5.65	5.91	1.28	0.00	0.00	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	37.25	4.35	5.81	1.94	0.00	0.00	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	39.50	5.50	5.50	1.63	0.00	0.00	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	50.94	6.18	4.42	2.65	0.00	0.00	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	79.75	7.30	11.21	5.73	0.00	0.00	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	117.03	22.86	2.06	1.60	0.23	0.23	0.46
clear cell carcinoma cell line:TEN	10636-108I6	136.55	7.98	5.38	5.90	0.17	0.17	0.52
colon carcinoma cell line:CACO-2	10513-107D9	85.30	4.76	5.49	2.75	0.00	0.00	0.37
colon carcinoma cell line:COLO-320	10420-106C6	107.94	9.88	14.06	1.14	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	61.88	2.38	4.76	3.57	0.00	0.00	1.19
colon, adult, pool1	10014-101C5	132.31	4.35	6.46	5.64	0.00	0.00	1.18
colon, fetal, donor1	10070-101I7	38.32	1.85	9.27	7.42	0.00	0.62	0.62
common myeloid progenitor CMP, donor1	12130-128D6	4.58	0.00	59.59	13.75	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	175.26	50.07	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	220.12	13.60	9.77	11.90	0.42	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	359.22	16.90	6.19	5.74	0.00	0.15	1.96
cord blood derived cell line:COBL-a untreated	10449-106F8	387.36	21.29	7.05	5.36	0.00	0.00	1.55
corpus callosum, adult, pool1	10042-101F6	18.69	2.54	14.48	4.75	0.00	0.00	0.00
cruciate ligament, donor2	10295-104G7	42.14	4.05	10.54	5.67	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	30.50	1.61	4.01	6.42	0.00	0.00	0.00
diencephalon, adult	10193-103E4	12.00	1.44	9.60	2.88	0.00	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	123.30	8.27	8.50	8.73	0.00	0.00	0.69
ductal cell carcinoma cell line:KLM-1	10438-106E6	114.37	6.67	1.03	4.62	0.00	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	55.37	4.81	1.69	3.85	0.00	0.00	0.00
ductus deferens, adult	10196-103E7	44.35	6.98	24.92	28.90	0.50	0.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	110.90	2.88	5.76	11.52	0.00	0.00	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	133.89	7.36	8.83	11.77	0.00	0.00	0.74
dura mater, adult, donor1	10041-101F5	110.91	6.19	4.54	5.04	0.66	0.41	1.16
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	61.96	4.66	17.54	9.10	0.44	1.11	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	40.70	2.87	5.73	2.15	0.00	0.00	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	38.85	5.55	4.32	7.40	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	36.33	6.05	2.42	2.72	0.00	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	37.98	5.25	4.63	6.17	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	57.79	3.94	3.94	13.13	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	102.57	9.39	27.82	21.79	0.00	0.34	1.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	67.06	9.06	16.67	8.16	0.18	0.18	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	85.71	7.56	4.50	4.99	0.00	0.00	0.32
epidermoid carcinoma cell line:A431	10426-106D3	129.28	5.78	1.33	4.67	0.11	0.11	1.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	83.26	4.73	0.77	0.99	0.00	0.00	0.33
epididymis, adult	10197-103E8	51.49	8.16	19.68	18.21	0.00	0.00	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	90.12	15.43	5.50	2.48	1.06	0.18	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	123.08	3.15	1.18	1.18	0.39	1.18	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	142.32	9.70	2.88	2.62	0.00	0.00	0.52
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	119.48	6.10	4.13	5.02	0.20	0.10	0.59
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	143.96	8.18	2.80	2.69	0.00	0.00	1.12
esophagus, adult, pool1	10015-101C6	49.59	3.50	3.50	5.20	0.11	0.11	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	34.31	6.51	22.42	11.90	0.00	0.00	0.00
eye - muscle inferior rectus, donor1	10272-104E2	28.97	4.83	21.73	19.32	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	65.23	4.21	4.21	2.10	0.00	2.10	0.00
eye - muscle medial, donor2	10299-104H2	62.51	8.93	10.42	11.91	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	52.74	3.44	9.17	8.03	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	40.81	1.46	13.12	5.83	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	13.73	2.54	10.93	4.58	0.25	0.00	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	63.47	5.00	2.18	2.31	0.00	0.00	1.15
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	119.42	10.21	4.04	3.09	0.00	0.00	0.95
frontal lobe, adult, pool1	10040-101F4	10.23	1.41	12.57	3.38	0.00	0.00	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	197.56	11.71	8.11	14.71	0.30	0.00	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	116.22	10.52	2.83	2.38	0.09	0.27	0.64
gall bladder, adult	10198-103E9	73.64	4.10	8.21	7.00	0.24	0.00	0.48
gamma delta positive T cells, donor1	11937-126A2	322.65	15.03	13.96	10.20	0.00	0.00	3.76
gamma delta positive T cells, donor2	11938-126A3	209.90	10.46	9.34	5.23	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	94.20	4.65	3.80	6.76	0.21	0.00	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	104.06	8.51	4.45	3.67	0.00	0.00	0.19
gastric cancer cell line:AZ521	10549-107H9	60.50	7.05	15.41	3.44	0.16	0.00	0.00
gastric cancer cell line:GSS	10560-108A2	8.24	0.92	7.32	1.83	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	61.00	4.34	16.45	7.77	0.00	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	32.82	2.75	2.07	1.72	0.00	0.00	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	34.15	5.60	2.52	1.82	0.14	0.00	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	37.41	3.49	10.97	8.98	0.00	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	50.14	4.96	4.33	1.90	0.32	0.00	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	53.79	4.07	3.79	2.11	0.28	0.00	0.42
glioblastoma cell line:T98G	10485-107A8	134.99	8.50	2.76	1.32	0.22	0.00	0.55
glioma cell line:GI-1	10413-106B8	51.84	2.64	1.76	4.69	0.00	0.29	0.29
globus pallidus - adult, donor10196	10175-103C4	22.60	1.46	16.76	5.10	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	43.69	7.08	22.94	10.98	0.00	0.00	0.00
globus pallidus, adult, donor10258	10367-105F7	20.54	5.48	20.54	5.48	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	21.85	2.66	10.66	6.40	0.00	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	26.92	0.00	14.68	2.45	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	174.85	32.79	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	517.43	31.36	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	37.44	4.80	3.20	1.60	0.00	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	57.39	8.26	4.59	2.30	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	53.50	2.29	3.20	3.66	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	61.83	5.15	5.15	3.22	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	60.37	2.87	1.44	5.75	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	58.98	2.74	5.49	4.12	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	22.07	1.10	13.24	8.83	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	108.04	8.05	17.24	12.36	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	26.31	5.38	3.89	3.59	0.00	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	38.96	4.45	7.06	1.57	0.00	0.00	0.26
heart - tricuspid valve, adult	10207-103F9	91.59	11.66	4.16	5.83	0.00	0.00	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	31.63	6.33	2.24	3.67	0.00	0.00	0.00
heart, adult, diseased, donor1	10051-101G6	33.21	3.83	1.28	0.00	0.00	0.00	0.43
heart, adult, pool1	10016-101C7	38.41	5.29	1.15	0.23	0.00	0.00	0.00
heart, fetal, pool1	10046-101G1	45.18	6.67	5.54	1.95	0.10	0.00	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	38.26	4.32	1.23	0.93	0.31	0.31	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	34.49	3.57	9.51	5.95	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	387.51	16.24	19.45	9.39	0.22	0.22	3.09
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	441.07	19.42	24.15	8.74	0.12	0.00	2.18
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	389.66	15.56	24.76	9.40	0.10	0.20	2.93
hepatoma cell line:Li-7	10484-107A7	126.90	2.89	1.11	1.78	0.22	0.00	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	301.50	10.55	5.93	4.02	0.20	0.00	4.62
hippocampus - adult, donor10196	10169-103B7	20.82	1.89	10.41	6.62	0.00	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	21.84	3.47	21.84	9.39	0.00	0.00	0.20
hippocampus, adult, donor10258	10374-105G5	7.47	1.49	11.95	1.99	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	17.27	1.41	15.86	4.93	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	109.86	15.26	12.21	6.10	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	62.64	8.05	10.60	5.50	0.00	0.00	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	71.09	7.62	10.41	4.32	0.00	0.00	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	38.91	9.02	27.63	12.97	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	41.31	8.52	22.46	5.94	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	46.69	7.21	20.88	8.73	0.00	0.00	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	43.50	4.96	40.58	17.81	0.29	0.29	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	41.79	4.74	33.61	13.14	0.00	0.00	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	30.45	3.75	35.87	22.52	0.00	0.00	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	53.99	4.03	16.10	9.47	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	40.34	6.11	16.88	11.73	0.16	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	62.62	4.71	15.49	10.10	0.67	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	64.63	5.95	7.82	3.60	0.00	0.00	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	79.10	5.90	8.84	3.93	0.00	0.00	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	101.24	19.20	15.71	2.62	0.00	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	41.24	8.59	32.45	6.68	0.00	0.00	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	40.55	7.85	28.34	7.85	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	61.47	11.99	39.98	10.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	36.92	6.41	21.48	9.80	0.38	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	43.65	5.00	25.46	10.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	38.21	6.58	26.31	10.96	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	27.76	5.72	25.64	9.96	0.00	0.00	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	34.55	6.97	23.52	6.39	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	35.57	5.98	26.60	12.85	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	71.68	8.31	11.08	5.73	0.00	0.00	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	61.05	7.42	9.98	2.57	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	113.92	7.35	14.29	8.17	0.00	0.00	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	49.64	3.87	20.42	6.34	0.35	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	38.64	4.12	23.76	5.70	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	61.13	7.57	30.56	6.36	0.00	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	26.89	4.14	39.82	11.89	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	33.21	3.32	51.14	11.29	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	31.30	4.87	39.25	11.54	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	30.68	2.56	22.50	9.97	0.00	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	31.05	6.82	36.35	11.36	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	33.94	5.38	25.88	12.77	0.34	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	69.55	7.00	12.56	3.86	0.24	0.00	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	74.43	9.36	12.48	7.58	0.45	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	73.17	10.24	19.02	5.37	0.00	0.00	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	32.09	4.58	31.17	6.72	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	165.92	16.27	6.51	13.01	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	58.25	6.29	41.04	8.60	0.00	0.00	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	35.57	2.74	37.22	18.06	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	43.79	4.34	39.08	20.63	0.36	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	44.84	3.91	41.64	14.59	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	34.61	3.58	26.25	7.16	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	41.44	4.88	28.30	12.87	0.00	0.00	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	29.63	3.50	28.29	12.93	0.00	0.00	0.27
immature langerhans cells, donor1	11904-125F5	61.99	7.02	2.42	2.66	0.48	0.48	0.24
immature langerhans cells, donor2	11905-125F6	53.86	10.30	1.58	3.17	0.79	0.00	0.00
insula, adult, pool1	10039-101F3	10.22	2.37	15.24	4.26	0.09	0.00	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	36.74	1.95	2.93	6.83	0.00	0.00	0.33
kidney, adult, pool1	10017-101C8	104.43	6.21	4.01	2.20	0.30	0.10	0.00
kidney, fetal, pool1	10045-101F9	38.69	3.54	11.81	4.67	0.07	0.00	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	96.43	12.21	13.92	3.83	0.14	0.14	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	50.32	8.02	3.87	4.84	0.00	0.00	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	46.61	2.57	1.47	2.94	0.00	0.00	0.18
left atrium, adult, donor1	10079-102A7	27.79	5.45	1.09	1.09	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	38.43	4.05	0.00	0.00	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	90.84	8.76	4.65	3.56	0.27	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	71.85	8.26	1.44	2.16	0.36	1.08	0.36
leiomyoma cell line:15242A	10570-108B3	72.83	7.07	0.54	0.54	1.09	0.54	0.00
leiomyoma cell line:15425	10571-108B4	77.70	7.53	1.70	0.97	0.73	0.49	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	6.35	6.35	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	17.77	1.05	3.14	3.14	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	216.40	10.74	3.78	4.01	0.12	0.12	0.83
liposarcoma cell line:KMLS-1	10782-110G8	70.61	5.94	2.66	1.56	0.47	0.47	0.00
liposarcoma cell line:SW 872	10726-110A6	169.60	8.29	4.87	5.12	0.12	0.00	2.44
liver, adult, pool1	10018-101C9	149.74	3.24	2.92	3.08	0.00	0.00	1.30
liver, fetal, pool1	10086-102B5	44.21	0.94	5.64	5.64	0.00	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	10.79	3.06	15.75	7.29	0.00	0.00	0.15
locus coeruleus, adult, donor10252	10165-103B3	29.53	3.32	16.24	8.49	0.00	0.00	0.00
locus coeruleus, adult, donor10258	10375-105G6	15.24	2.26	6.77	5.64	0.28	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	42.06	3.79	20.19	13.46	0.00	0.42	0.00
lung adenocarcinoma cell line:A549	10499-107C4	42.90	5.95	4.57	1.66	0.14	0.00	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	23.44	1.38	2.76	5.52	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	66.83	17.53	6.59	3.30	0.13	0.00	0.13
lung, adult, pool1	10019-101D1	59.06	4.61	3.78	3.54	0.00	0.00	1.06
lung, fetal, donor1	10068-101I5	54.51	4.28	40.53	6.28	0.29	0.00	0.00
lung, right lower lobe, adult, donor1	10075-102A3	71.94	6.87	11.00	11.91	0.00	0.46	0.46
lymph node, adult, donor1	10077-102A5	80.00	6.63	3.31	1.89	0.95	0.00	1.42
lymphangiectasia cell line:DS-1	10727-110A7	151.23	6.36	10.74	4.82	0.00	0.00	4.38
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	306.83	11.47	5.13	2.11	0.00	0.00	2.26
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	170.75	5.10	1.70	7.65	0.00	0.85	0.00
mature adipocyte, donor1	12231-129F8	15.10	1.78	4.88	1.78	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	23.87	3.11	2.91	1.45	0.00	0.21	0.00
mature adipocyte, donor3	12233-129G1	20.15	3.32	3.08	0.71	0.00	0.00	0.00
mature adipocyte, donor4	12234-129G2	18.43	3.42	2.37	1.58	0.00	0.00	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	36.45	5.48	14.53	7.15	0.00	0.00	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	9.02	0.00	12.41	6.77	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	16.92	2.39	20.60	11.03	0.00	0.00	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	6.04	1.27	18.43	4.45	0.00	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	21.32	4.69	15.35	6.40	0.43	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	11.64	1.86	17.38	11.14	0.17	0.00	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	18.46	2.97	23.56	9.34	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	15.41	1.93	3.85	1.93	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	14.35	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	14.00	2.51	21.54	6.46	0.00	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	22.07	4.54	9.09	3.89	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	27.56	2.32	15.33	6.50	0.00	0.00	0.00
medulla oblongata, adult, pool1	10038-101F2	23.26	2.37	11.84	4.24	0.00	0.00	0.24
medulla oblongata, newborn, donor10223	10361-105F1	41.66	2.08	12.85	6.60	0.00	0.69	0.00
medulloblastoma cell line:D283 Med	10838-111E1	36.53	1.55	20.37	4.65	0.00	0.00	0.00
medulloblastoma cell line:ONS-76	10759-110E3	34.85	3.30	1.96	1.35	0.12	0.00	0.61
melanoma cell line:COLO 679	10514-107E1	39.67	3.88	1.72	2.73	0.00	0.00	0.00
melanoma cell line:G-361	10465-106H6	24.97	4.07	2.17	3.26	0.00	0.00	0.27
meningioma cell line:HKBMM	10691-109F7	141.11	9.59	1.45	4.34	0.36	0.00	1.63
merkel cell carcinoma cell line:MKL-1	10843-111E6	66.97	13.22	26.43	9.69	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	45.36	7.00	22.29	8.55	0.00	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	78.10	9.51	1.53	1.07	0.31	0.00	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	53.44	6.36	1.27	0.73	0.00	0.18	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	49.69	5.38	2.07	0.41	0.00	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	57.45	6.04	0.56	0.84	0.42	0.14	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	50.45	6.16	1.35	1.54	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	90.23	9.02	3.47	7.63	0.00	1.39	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	81.87	7.04	1.03	2.40	0.17	0.17	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	48.31	5.06	1.04	1.84	0.12	0.12	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	63.40	10.08	1.33	0.93	0.13	0.00	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	68.87	10.40	1.62	1.22	0.27	0.00	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	58.61	7.40	1.00	0.57	0.14	0.14	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	102.76	6.59	4.94	3.95	0.00	0.00	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	83.58	8.16	1.66	0.55	0.97	0.42	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	107.17	11.52	1.75	2.09	0.35	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	62.88	8.37	1.02	0.61	0.20	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	56.07	6.83	2.16	2.16	0.00	0.72	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	47.59	6.72	1.14	0.41	0.21	0.41	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	58.59	4.10	0.46	1.14	1.14	1.14	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	79.30	10.49	1.68	0.84	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	118.06	10.31	2.09	1.05	1.05	0.45	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	68.45	9.37	1.66	0.70	0.18	0.09	0.53
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	55.96	7.00	1.10	1.10	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	57.52	5.15	1.14	1.43	0.29	0.86	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	103.15	10.10	3.79	3.37	0.00	0.84	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	49.32	8.22	1.83	0.91	0.00	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	44.25	3.84	1.53	1.28	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	42.14	5.50	2.62	2.62	0.00	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	45.60	4.01	1.54	2.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	39.07	6.35	2.35	0.94	0.47	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	46.71	5.75	0.68	2.03	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	36.55	4.72	1.96	1.96	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	44.49	10.19	1.39	2.78	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	48.74	8.65	2.02	1.73	0.00	0.58	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	36.81	7.14	2.45	0.67	0.22	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	43.26	6.25	2.64	2.64	0.00	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	31.53	4.40	4.40	2.93	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	42.96	7.72	1.68	1.34	0.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	49.53	6.55	0.41	3.68	1.23	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	39.09	7.30	1.72	1.72	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	57.42	5.47	2.73	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	56.81	0.00	0.00	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	50.67	5.52	1.30	3.25	0.32	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	33.46	1.45	2.91	4.36	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	36.78	4.80	2.13	1.60	0.00	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	33.53	7.36	0.00	3.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	26.43	8.94	1.17	2.33	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	37.78	4.20	0.00	0.00	0.00	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	53.65	4.97	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	66.74	9.53	4.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	46.84	6.52	1.78	1.78	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	40.21	7.31	1.22	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	38.64	10.77	2.53	2.53	0.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	18.97	3.79	3.10	2.07	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	27.94	2.15	0.00	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	27.94	0.00	7.98	3.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	0.00	0.00	20.66	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	24.04	1.22	3.26	5.70	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	24.63	1.59	1.59	5.56	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	12.38	2.95	5.31	4.13	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	15.59	1.87	3.74	4.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	26.73	1.34	6.68	5.35	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	35.48	4.73	3.55	3.55	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	53.93	0.00	2.57	2.57	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	36.49	2.75	1.38	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	36.62	2.97	1.98	2.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	28.04	2.24	2.24	1.12	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	39.44	8.27	3.82	3.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	41.51	7.25	1.61	1.61	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	43.61	6.54	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	38.01	10.14	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	33.38	2.43	1.82	1.21	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	27.11	9.04	4.52	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	25.53	3.29	4.94	2.47	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	31.35	3.97	2.58	0.99	0.00	0.00	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	26.61	5.84	2.27	2.27	0.32	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	26.48	2.04	4.07	3.06	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	50.29	5.42	10.06	6.96	0.00	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	103.71	10.16	4.02	2.36	0.47	0.94	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	164.72	12.97	5.56	5.56	4.63	5.10	0.93
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	188.04	8.55	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	249.27	15.00	0.92	3.08	0.72	2.06	1.34
mesothelioma cell line:Mero-25	10850-111F4	109.16	6.13	0.68	3.40	0.23	0.91	0.23
mesothelioma cell line:Mero-41	10851-111F5	74.32	7.33	1.47	0.98	0.24	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	49.16	6.20	0.44	1.33	0.22	0.22	0.00
mesothelioma cell line:Mero-82	10853-111F7	217.87	9.20	3.94	4.20	1.31	1.31	1.84
mesothelioma cell line:Mero-83	10854-111F8	75.24	4.26	1.19	2.89	0.17	0.51	0.68
mesothelioma cell line:Mero-84	10855-111F9	71.54	7.33	1.77	0.76	0.00	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	79.71	6.83	2.07	3.11	0.83	0.00	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	68.58	6.13	0.99	1.16	0.00	0.00	0.17
mesothelioma cell line:NCI-H226	10846-111E9	148.05	7.60	1.27	2.35	8.51	6.70	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	141.61	7.17	2.56	2.90	0.85	1.02	1.02
mesothelioma cell line:NCI-H28	10845-111E8	29.01	2.04	1.02	0.51	0.00	0.00	0.25
mesothelioma cell line:No36	10857-111G2	84.81	4.24	0.33	1.30	0.33	0.00	0.98
mesothelioma cell line:ONE58	10858-111G3	91.85	4.61	0.27	0.54	0.54	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	122.83	9.60	3.84	2.11	0.19	0.00	0.38
migratory langerhans cells, donor2	11902-125F3	104.65	10.62	4.64	1.10	0.12	0.00	0.49
migratory langerhans cells, donor3	11903-125F4	142.33	10.59	11.67	7.18	0.54	0.00	0.90
mixed mullerian tumor cell line:HTMMT	10689-109F5	214.17	8.49	3.26	5.55	0.33	0.00	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	201.98	19.71	2.33	2.12	0.85	0.85	1.06
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	119.09	12.21	2.53	11.52	0.00	0.00	1.84
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	240.15	13.32	5.71	2.66	0.00	0.19	3.23
myelodysplastic syndrome cell line:SKM-1	10772-110F7	166.68	9.98	9.42	6.47	0.00	0.00	0.74
myeloma cell line:PCM6	10474-106I6	115.24	4.55	14.63	9.88	0.00	0.00	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	81.67	11.16	0.51	4.06	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	85.71	5.69	5.49	7.26	0.20	0.00	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	15.93	2.34	2.12	4.46	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	18.61	1.62	3.24	5.15	0.07	0.15	0.22
nasal epithelial cells, donor2	12227-129F4	20.42	2.21	1.66	1.10	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	16.10	1.38	24.62	4.14	0.00	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	112.81	10.85	8.79	3.18	0.19	0.00	1.12
neuroblastoma cell line:NBsusSR	10607-108F4	45.13	2.95	9.70	4.43	0.00	0.00	0.21
neuroblastoma cell line:NH-12	10555-107I6	41.93	3.91	10.99	6.15	0.00	0.00	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	6.88	0.47	39.14	7.12	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	38.17	5.54	8.39	4.91	0.16	0.00	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	33.41	5.43	16.91	5.23	0.00	0.00	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	8.26	1.27	8.26	0.64	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	57.23	6.12	1.86	1.33	0.53	0.00	0.27
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	9.47	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	156.27	10.65	32.13	3.21	0.00	0.00	1.52
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	117.67	13.61	10.41	3.20	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	38.79	6.73	3.53	4.49	0.32	0.32	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	271.44	10.77	2.89	4.47	0.79	1.31	2.36
nucleus accumbens, adult, pool1	10037-101F1	11.53	2.16	16.97	3.00	0.19	0.00	0.09
occipital cortex - adult, donor10196	10172-103C1	8.24	4.12	12.36	4.12	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	26.84	2.42	24.15	13.69	0.00	0.27	0.27
occipital cortex, newborn, donor10223	10355-105E4	18.56	0.73	18.20	5.46	0.00	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	13.91	1.57	12.86	4.72	0.00	0.00	0.26
occipital lobe, fetal, donor1	10073-102A1	5.15	2.15	40.76	9.87	0.00	0.00	0.00
occipital pole, adult, pool1	10036-101E9	7.65	1.50	12.69	3.23	0.08	0.00	0.00
olfactory region, adult	10195-103E6	12.42	1.53	12.23	5.54	0.00	0.00	0.00
optic nerve, donor1	10277-104E7	6.00	0.00	16.01	4.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	96.14	2.05	3.30	2.73	0.00	0.11	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	73.64	9.34	5.50	3.85	0.14	0.14	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	142.23	7.11	1.52	5.25	0.51	0.17	0.85
oral squamous cell carcinoma cell line:SAS	10544-107H4	75.77	4.27	0.92	4.74	0.35	0.00	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	33.51	4.41	2.65	1.47	0.00	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	39.24	2.80	1.87	4.67	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	63.62	5.94	4.88	1.70	0.21	0.21	0.00
ovary, adult, pool1	10020-101D2	43.06	5.07	4.89	4.02	0.09	0.00	0.79
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	113.84	10.08	5.13	3.12	0.92	0.73	0.55
pancreas, adult, donor1	10049-101G4	49.85	9.41	5.64	5.64	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	27.67	0.84	4.47	8.39	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	118.74	5.11	0.85	3.24	0.17	0.17	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	79.65	3.81	3.97	5.30	0.00	0.00	0.66
paracentral gyrus, adult, pool1	10035-101E8	7.87	1.46	12.81	3.84	0.00	0.00	0.09
parietal cortex, adult, donor10258	10373-105G4	6.61	2.20	14.68	5.14	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	12.23	3.76	10.35	6.58	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	16.82	2.57	18.81	7.13	0.00	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	7.75	1.06	14.36	4.23	0.00	0.00	0.09
parietal lobe, fetal, donor1	10072-101I9	9.70	0.97	47.52	3.88	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	20.94	1.87	19.81	8.60	0.00	0.00	0.00
parotid gland, adult	10199-103F1	77.08	9.25	4.32	4.93	0.00	0.00	0.00
penis, adult	10200-103F2	30.62	2.15	6.98	6.45	0.00	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	18.41	1.12	4.28	3.16	0.19	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	186.05	10.64	3.93	4.66	0.15	0.00	1.75
pineal gland - adult, donor10196	10179-103C8	10.97	3.23	47.09	14.19	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	20.73	4.74	50.34	10.07	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	14.42	0.63	57.06	14.42	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	42.50	12.14	32.38	9.11	1.01	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	57.85	7.82	46.38	13.55	0.00	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	43.41	5.96	53.63	9.36	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	59.88	5.81	3.12	4.09	0.11	0.00	0.75
plasma cell leukemia cell line:ARH-77	10840-111E3	213.87	11.92	8.48	3.31	0.26	0.00	1.46
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	43.27	2.65	2.65	2.18	0.00	0.00	0.16
pons, adult, pool1	10033-101E6	11.19	1.98	8.95	3.10	0.09	0.00	0.09
postcentral gyrus, adult, pool1	10032-101E5	7.85	2.01	9.33	4.01	0.00	0.00	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	6.27	0.00	2.09	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	143.21	27.54	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	211.24	11.74	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	80.26	6.26	3.20	1.60	0.29	0.00	0.00
prostate cancer cell line:PC-3	10439-106E7	126.14	11.43	5.63	4.72	0.00	0.00	0.36
prostate, adult, pool1	10022-101D4	44.08	5.17	8.89	6.53	0.00	0.09	0.36
putamen, adult, donor10196	10176-103C5	10.15	0.94	30.69	4.49	0.00	0.00	0.00
putamen, adult, donor10252	10152-102I8	39.21	1.96	19.61	9.80	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	22.95	1.09	8.74	2.19	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	6.28	2.90	20.30	2.42	0.00	0.00	0.00
putamen, newborn, donor10223	10365-105F5	25.49	1.50	21.74	9.00	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	72.73	3.49	1.45	6.98	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	43.12	4.17	27.82	6.95	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	79.71	6.78	4.88	1.70	0.00	1.27	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	79.53	4.14	0.83	0.83	2.90	3.73	0.00
retina, adult, pool1	10030-101E3	27.04	4.17	14.21	4.97	0.10	0.00	0.10
retinoblastoma cell line:Y79	10475-106I7	52.22	4.94	16.11	2.34	0.00	0.00	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	271.59	16.84	11.19	6.39	0.49	0.00	2.34
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	67.49	7.31	11.81	4.78	0.00	0.00	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	15.91	3.03	11.37	4.55	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	39.98	2.43	5.02	8.58	0.49	0.16	0.00
salivary acinar cells, donor2	11772-123I8	33.60	2.20	11.98	11.43	0.14	0.55	0.14
salivary acinar cells, donor3	11773-123I9	16.55	3.31	10.59	10.59	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	87.51	4.58	4.00	3.43	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	24.96	4.22	3.20	2.70	0.00	0.08	0.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	27.51	3.41	3.76	2.47	0.00	0.12	0.12
seminal vesicle, adult	10201-103F3	58.20	4.76	27.51	27.51	0.00	0.00	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	82.84	5.59	6.56	10.45	0.24	0.49	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	25.67	2.26	0.75	0.75	0.00	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	44.16	7.02	1.00	1.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	80.19	5.10	6.72	5.78	0.00	0.00	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	100.25	3.43	4.97	2.54	0.11	0.00	0.99
signet ring carcinoma cell line:NUGC-4	10483-107A6	132.25	6.06	2.84	3.74	0.00	0.26	1.16
skeletal muscle - soleus muscle, donor1	10282-104F3	31.21	4.26	3.55	3.55	0.71	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	27.71	3.84	3.24	1.20	0.00	0.24	0.24
skeletal muscle, fetal, donor1	10066-101I3	26.13	4.02	0.00	4.02	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	27.14	0.00	6.79	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	34.09	4.42	15.15	6.94	0.00	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	78.38	12.01	5.34	4.67	0.33	0.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	55.79	5.99	21.43	9.46	0.00	0.00	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	23.13	15.42	7.32	1.35	0.00	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	32.14	3.13	11.70	5.27	0.00	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	19.46	1.61	11.90	1.61	0.00	0.00	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	249.95	11.33	22.45	5.67	0.22	0.00	1.09
small intestine, adult, pool1	10024-101D6	383.05	5.85	6.09	5.97	0.00	0.24	4.18
small intestine, fetal, donor1	10064-101I1	199.26	5.41	5.90	6.39	0.00	0.00	2.21
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	88.22	6.67	13.34	15.90	0.00	0.00	0.51
smooth muscle, adult, pool1	10048-101G3	15.25	3.10	4.14	2.58	0.26	0.26	0.00
somatostatinoma cell line:QGP-1	10781-110G7	34.84	2.14	8.58	13.67	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	21.11	3.67	14.22	9.18	0.00	0.00	0.00
spinal cord, adult, donor10252	10159-103A6	23.66	3.94	11.83	6.31	0.00	0.00	0.39
spinal cord, adult, donor10258	10369-105F9	20.75	2.77	15.22	6.92	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	29.88	4.88	15.25	6.10	0.00	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	40.41	6.43	20.21	5.05	0.00	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	34.95	4.33	1.34	2.24	0.15	0.15	0.45
spleen, adult, pool1	10025-101D7	169.83	7.93	4.19	2.97	0.22	0.11	2.53
spleen, fetal, pool1	10044-101F8	88.12	5.96	8.18	4.69	0.08	0.40	1.83
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	269.96	7.87	13.15	7.14	0.21	0.00	1.76
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	227.28	17.28	15.00	12.34	0.38	0.19	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	51.72	10.48	4.54	6.29	0.35	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	132.13	5.47	1.56	4.69	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	62.36	2.81	5.63	9.57	0.11	0.11	0.56
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	90.65	3.81	2.97	4.66	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	87.58	7.62	2.54	0.85	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	55.53	5.34	11.75	7.48	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	66.65	5.13	7.98	9.11	0.00	1.14	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	27.83	3.12	15.37	7.27	0.00	0.00	0.00
substantia nigra, adult, donor10258	10371-105G2	8.79	2.07	11.90	2.59	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	26.85	5.65	16.25	7.07	0.71	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	63.51	8.02	6.42	1.38	0.23	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	8.22	1.95	11.19	3.90	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	11.40	2.14	46.30	4.27	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	10.55	3.08	29.45	4.83	0.00	0.00	0.00
tenocyte, donor1	11763-123H8	77.85	6.98	1.40	3.14	0.00	0.35	0.70
tenocyte, donor2	11765-123I1	49.21	2.67	3.82	4.20	0.00	0.00	0.00
tenocyte, donor3	11768-123I4	36.70	5.93	1.11	2.97	0.37	0.37	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	31.44	3.74	7.65	4.76	0.00	0.00	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	72.91	5.40	9.40	3.24	0.00	0.00	0.62
teratocarcinoma cell line:PA-1	10807-111A6	45.72	6.04	3.87	3.87	0.15	0.00	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	31.23	3.68	1.90	6.86	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	19.66	2.27	9.08	10.21	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	21.05	2.07	1.09	7.96	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	56.02	5.21	1.30	0.98	0.00	0.00	0.00
testis, adult, pool1	10026-101D8	23.62	3.97	10.42	3.97	0.00	0.32	0.11
testis, adult, pool2	10096-102C6	13.98	1.35	14.43	4.96	0.00	0.00	0.00
thalamus - adult, donor10196	10168-103B6	18.77	1.10	12.14	4.42	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	23.44	3.75	18.91	8.13	0.00	0.16	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	16.94	0.00	4.62	3.08	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	9.06	2.14	10.54	8.89	0.00	0.00	0.16
thalamus, newborn, donor10223	10366-105F6	14.96	1.15	11.51	8.05	0.00	0.00	0.00
throat, adult	10209-103G2	63.67	7.24	9.24	7.24	0.00	0.25	0.25
throat, fetal, donor1	10061-101H7	36.26	5.48	19.20	10.06	0.00	0.00	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	91.81	8.94	22.85	5.37	0.00	0.00	0.20
thymus, adult, pool1	10027-101D9	86.69	8.15	10.84	2.49	0.30	0.30	0.30
thymus, fetal, pool1	10043-101F7	80.21	6.03	36.68	6.44	0.31	0.10	0.52
thyroid carcinoma cell line:KHM-5M	10776-110G2	97.73	6.38	1.73	1.60	0.00	0.00	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	92.48	9.50	1.26	3.21	0.00	0.00	0.84
thyroid, adult, pool1	10028-101E1	76.42	6.81	8.12	3.64	0.09	0.09	0.93
thyroid, fetal, donor1	10060-101H6	32.96	6.86	21.09	10.81	0.00	0.00	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	58.51	0.00	15.40	24.64	0.00	0.00	0.00
tongue, adult	10203-103F5	62.33	5.35	4.88	3.26	0.47	0.23	0.23
tongue, fetal, donor1	10059-101H5	46.11	5.12	6.31	3.55	0.00	0.00	0.39
tonsil, adult, pool1	10047-101G2	110.59	6.61	9.82	5.71	0.60	0.20	1.00
trachea, adult, pool1	10029-101E2	73.70	5.64	3.68	4.99	0.25	0.00	0.98
trachea, fetal, donor1	10058-101H4	41.93	4.23	7.31	7.31	0.00	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	75.46	4.96	1.42	1.77	0.35	0.00	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	111.35	5.07	4.26	3.24	0.10	0.00	1.01
transitional-cell carcinoma cell line:JMSU1	10492-107B6	154.18	15.20	4.86	2.82	1.10	0.31	0.94
tridermal teratoma cell line:HGRT	10694-109G1	30.44	3.81	3.81	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	47.15	4.15	3.05	2.62	0.00	0.00	0.42
umbilical cord, fetal, donor1	10057-101H3	18.78	2.09	6.26	4.17	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	43.85	3.75	12.80	3.24	0.17	0.17	0.00
uterus, fetal, donor1	10055-101H1	26.11	4.61	21.50	9.73	0.00	0.00	0.00
vagina, adult	10204-103F6	32.96	3.23	5.82	6.46	0.00	0.00	0.00
vein, adult	10191-103E2	51.95	4.38	9.64	5.48	0.00	0.44	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	239.00	13.35	7.21	5.07	0.53	0.27	1.60